Page last updated: 2024-09-03

tamsulosin and Adenoma, Prostatic

tamsulosin has been researched along with Adenoma, Prostatic in 580 studies

Research

Studies (580)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	61 (10.52)	18.2507
2000's	212 (36.55)	29.6817
2010's	248 (42.76)	24.3611
2020's	59 (10.17)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Arredondo, NF; Bantle, GW; Blue, DR; Clarke, DE; DeSousa, A; Elworthy, TR; Ford, AP; Gross, LM; Kava, MS; Lesnick, JD; Morgans, DJ; Ozer, RS; Palmer, WS; Pfister, JR; Repke, DB; Romero, M; Sandoval, L; Sjogren, EB; Talamás, FX; Vazquez, A; Vimont, RL; Williams, TJ; Wu, H; Zhu, QM	1
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Ehrlich, PP; Elmore, SW; Hancock, AA; Kerwin, JF; Lebold, SA; Meyer, MD; Plagge, F; Plata, DJ; Sippy, KB; Tietje, K; Wendt, MD	1
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Condon, S; Drizin, I; Elmore, SW; Hancock, AA; Kerwin, JF; Meyer, MD; Sippy, KB; Tietje, K; Wendt, MD	1
Cheung, P; Evangelisto, M; Jolliffe, L; Kuo, GH; Murray, WV; Prouty, C; Pulito, V; Varga, S; Wang, J	1
Barrish, A; Barrow, JC; Broten, TP; Chang, RS; Ellis, JD; Forray, C; Freidinger, RM; Gilbert, KF; Glass, KL; Homnick, CF; Kassahun, K; Kling, P; Leppert, P; Nagarathnam, D; Nantermet, PG; O'Malley, SS; Olah, TV; Ransom, RW; Reiss, D; Rittle, KE; Schorn, TW; Selnick, HG; Steele, TG	1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD	1
Chiu, G; Connolly, PJ; Li, S; Liu, J; Middleton, SA; Pulito, V	3
Chen, K; Jiang, Z; Liu, S; Xi, B; Yang, F; Zeng, LY; Zeng, Y	1
Alcaraz, A; Angulo, JC; Brenes-Bermúdez, FJ; Carballido-Rodríguez, J; Castro-Díaz, D; Cózar-Olmo, JM; Esteban-Fuertes, M; Fernández-Gómez, JM; Fernández-Pro Ledesma, A; Ficarra, V; Manasanch, J; Medina-Polo, J; Molero-García, JM; Palou, J; Pérez-León, N; Ponce de León Roca, J; Rodríguez-Antolín, A	1
Azoulay, L; Brasher, PMA; Cragg, JJ; Kuramoto, LK; Rosner, J; Sobolev, BG	1
Amirzargar, M; Biglarkhani, M; Shobeirian, F; Zerafatjou, N; Zoghi, G	1
Ayati, M; Fotovat, A; Momeni, SA; Nasseri, A; Nowroozi, MR; Samadzadeh, B; Sharifi, L; Yavari, S	1
Paulis, A; Paulis, G; Perletti, G	1
Bhak, RH; Cortes, V; Cunnington, M; Duh, MS; Kapse, P; Lulic, Z; Miller, D; Park, S; Son, H; Yoo, SB	1
Abdelhafez, AM; Gawad, DA; Hassan, EM; M Youssef, R	1
Kim, AR; Kwon, O; Lee, CL; Lee, JY; Lim, JS; Na, YG; Park, JM; Seo, BN; Seo, CS; Shin, HK; Shin, JH; Song, KH; Yang, SW	1
Matsuo, T; Miyata, Y; Sakai, H	1
Kim, JH; Lee, JW	1
King, B; Plochocki, A	1
Abdel Moneim, MM	1
Bakhaidar, RB; Bukhary, DM; Bukhary, HA; Hosny, KM; Madkhali, OA; Mahier, IM; Rizq, WY; Sabei, FY; Safhi, AY; Sultan, MH	1
Averbeck, MA; Concas, F; Cortés, V; Gravas, S; Kamola, PJ; Kattan, MW; Lulic, Z; Manyak, M; Oelke, M; Palacios-Moreno, JM; Roehrborn, CG; Thompson, D	1
Narayanan, NS; Schultz, J; Simmering, JE; Welsh, MJ	1
Exintaris, B; Middendorff, R; Mietens, A; Seidensticker, M; Tasch, S	1
Kazikhinurov, AA; Kazikhinurov, RA; Kazikhinurova, KA; Pavlov, VN; Sabirzyanov, SS; Saleeva, YD	1
Abdullaev, SP; Shatokhin, MN; Sychev, DA; Teodorovich, OV	1
Budaya, TN; Daryanto, B; Naim, HY	1
Kawakami, Y; Kotake, K; Noritake, Y	1
Govorov, AV; Sarukhanian, AL	1
Hashizume, K; Kasamo, S; Matsumoto, S	1
Gittelman, M; Lowe, FC; Roehrborn, CG; Verbeek, AE; Wruck, JM	2
Ahmadi, A; Jahani Amiri, K; Mofarrah, R; Montazer, F; Nouripour, B	1
Akamatsu, S; Goto, T; Kobayashi, T; Matsubara, K; Matsui, Y; Negoro, H; Ogawa, O; Omura, T; Terada, N; Yamamoto, T; Yonezawa, A	1
Chapple, C; De Nunzio, C; Frizzi, J; Gacci, M; Gravas, S; Kaplan, SA; Maggi, M; McVary, KT; Saleh, O; Sebastianelli, A; Serni, S; Spatafora, P; Tubaro, A; Vignozzi, L	1
Adalig, B; Cortes, V; Eisen, C; Gilg, F; Hennig, M; Kostev, K; Lulic, Z; Palacios-Moreno, JM	1
Alves Terceiro Neto, J; Carvalho, ALM; Carvalho, IPS; Cavalcante, YTD; Ciríaco, SL; Cunha, APGP; da Silva, DTC; da Silva, JA; de Lima Chagas Moreno Fernandes, MZ; de Oliveira, DHB; de Sousa Lima Neto, J; Mineiro, ALBB	1
Rezk, MR; Tantawy, MA; Wadie, M; Weshahy, SA	1
Carini, M; Di Maida, F; Mari, A; Minervini, A; Rubino, R; Siena, G	1
Cambronero Santos, J; Chapple, C; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT; Schermer, CR; Staskin, D	1
Hori, Y; Ohyama, K; Sugiura, M	1
Giuliano, F; Lulic, Z; Manyak, MJ; Palacios-Moreno, JM; Roehrborn, CG; Rosen, RC; Wilson, TH	1
Ahn, ST; Jeong, HG; Kim, JW; Lee, DH; Moon, DG; Oh, MM; Park, HS	1
Chen, Z; Gao, Y; Liang, L; Lin, J; Liu, L; Su, S	1
Cai, Z; Li, H; Ma, C; Zhang, J	1
Peyronnet, B	1
Huang, H; Huang, WP; Ye, XT; Zhang, FY	1
Cai, Z; Li, H; Ma, C; Xiong, J; Zhang, J	1
Chen, X; Guo, B; Hou, H; Liu, M; Wang, M; Zhang, Z	1
Kim, JH; Kim, Y; Kwon, YS; Lee, JJ; Lee, SH; Sohn, JH	1
Gupta, S; Singh, I; Tk, A	1
Bolton, D; Chung, E; Donato, P; Morton, A; Perera, M; Ranasinghe, S; Roberts, MJ; Teloken, PE; Williams, M; Yaxley, J	1
Arita, R; Inoue, S; Itoh, K; Kawashima, M; Shimizu, S; Tsubota, K	1
El-Abd, AS; El-Abd, SA; Radwan, MH; Soliman, MG; Tawfik, AM	1
Ayyash, O; Bandari, J; Davies, BJ; Jacobs, BL; Kumar, P; Macleod, LC; Odisho, AY; Ogunmola, AG; Sabik, LM; Shah, AA; Yabes, JG	1
Aveta, A; Capece, M; Creta, M; Crocetto, F; Esposito, F; Fusco, F; Imbimbo, C; La Rocca, R; Longo, N; Mangiapia, F; Mirone, V; Trama, F	1
Cambronero Santos, J; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT	1
Chapple, C; Gacci, M; Gravas, S; Kaplan, S; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L	1
Chapple, C; Gacci, M; Gemma, L; Gravas, S; Kaplan, SA; Liaci, A; Maggi, M; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L; Zaccaro, C	1
Chavan, C; D'Agate, S; Della Pasqua, O; Manyak, M; Michel, MC; Oelke, M; Palacios-Moreno, JM; Roehrborn, CG	1
Kamoto, T; Tsukino, H	1
Burgio, KL; Falk, K; Goode, PS; Hammontree, L; Johnson, TM; Markland, AD; McGwin, G; Ouslander, JG; Vaughan, CP	1
Asakura, H; Seki, N; Tokunaga, S; Yamanishi, T	3
Barnes, CL; Bruha, MJ; Menendez, ME; Moverman, MA; Pagani, NR; Puzzitiello, RN	1
Behera, DP; Gupta, S; Singh, I; T K, A	1
Ergakov, DV; Martov, AG	3
Spalton, DJ	1
Chai, Y; Che, X; Cui, Y; Zhang, Y; Zhou, Z	1
Kanar, HS; Olcucu, MT; Ozdemir, I	1
Guo, J; Tang, R	1
Ghadian, A; Rezaei, M	1
Japing, WJ; Lubbers, SM	1
Chung, JI; Hong, JH; Jung, TY; Kang, TW; Kwak, C; Kwon, SY; Lee, JY; Lee, KS; Seo, SI; Yoo, TK; Yun, SJ	1
Ahn, TY; Hyun, JS; Jung, J; Kim, SW; Lee, SW; Min, KS; Moon, DG; Moon, KH; Park, JK; Park, K; Park, NC; Ryu, JK; Son, H; Yang, DY; Yang, SK	1
Dogan, M; Halat, AO; Karalar, M; Keles, I; Kutluksaman, B	1
Mironov, AV; Spivak, LG; Vinarov, AZ	1
Giuliano, F; Karanastasis, D; Manyak, MJ; Palacios-Moreno, JM; Plastino, J; Roehrborn, CG; Roos, EPM; Rosen, RC; Santos, JC; Wilson, TH	1
Farelo-Trejos, OL; García, MF; Monzó-Gardiner, JI; Paesano, NE; Serna-Hurtado, JJ	1
Gainullina, Y; Kosilov, K; Kosilova, L; Kuzina, I; Kuznetsov, V; Loparev, S; Prokofyeva, A	1
Kuandykov, YA; Shalekenov, BU; Shalekenov, SB	1
Di Clemente, L; Di Pasquale, AB; Masciovecchio, S; Ranieri, G; Romano, G	1
Khan, QS; Lokhande, A; Tucker, P	1
Albertsen, PC; Duan, Y; Grady, JJ; Helen Wu, Z	1
Bai, AD; Gill, SS	1
Chen, CL; Hou, CP; Lin, YH; Tsui, KH; Yang, PS	1
Bae, JH; Chang, IH; Chung, JH; Chung, JI; Ha, US; Han, DH; Han, JH; Jung, J; Kim, JH; Kim, SW; Kim, TH; Kim, YI; Lee, SH; Lee, SW; Oh, CY; Yoo, TK	1
Abdel Moneim, MM; Belal, SF; El-Kimary, EI; Khamis, EF	1
Bulut, AE; Esen, F; Toker, E	1
Gyaurgiev, TA; Kuzmenko, AV; Kuzmenko, VV	1
Branchi, A; Castellani, D; Claudini, R; Dellabella, M; Gasparri, L	1
Loran, OB; Seregin, AA	1
Kim, KA; Park, IB; Park, JY	1
Choi, BR; Karna, KK; Kim, HK; Lee, SW; Park, JK; So, I; Soni, KK	1
Tan, CK; Yap, KB	1
Apostolidis, A; Papathanasiou, A; Sakalis, V; Salpiggidis, G; Sfiggas, V; Vouros, I	1
Ameli, M; Ameli, Z; Baghani Aval, H	1
Madersbacher, S; Michel, MC	1
Haga, K; Hirose, T; Ichihara, K; Iwasawa, A; Masumori, N; Miyao, N; Nishimura, M; Sasamura, H; Suzuki, N; Taguchi, K; Yamaguchi, Y	1
Juzych, MS; Nariman, N; Pankratz, J; Rana, S; Rana, VK; Segars, L; Silverstein, SM; Stephens, R	1
Bjartell, A; Bolton, DM; Caris, C; Davis, NF; de la Taille, A; Jack, GS; Lawrentschuk, N; Patel, A; Tubaro, A; Witjes, WP	1
Wang, XP	1
Belal, F; Borg, H; Fathy, M; Walash, MI; Zayed, S	1
Bae, WJ; Cho, HJ; Choi, JB; Ha, US; Han, K; Hong, SH; Kim, SW; Lee, JY; Moon, HW; Park, SH; Yang, JH	1
Brotherton, B; Haque, N; Kuo, HC; Manyak, M; Masumori, N; McLaughlin, M; Muganurmath, C; Sakamoto, S; Wilson, T; Ye, Z; Yoon, SJ	1
Alcántara, A; Cózar, JM; Duran, A; Errando, C; Mora, AM; Rubio-Rodríguez, D; Rubio-Terrés, C	1
Kawahara, T	1
Ulrich, S	1
Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R	1
Cho, DH; Ha, JY; Jung, HJ; Kim, BH; Kim, BS; Kim, GN; Kim, JH; Kim, JS; Kim, KH; Kim, TH; Lee, YH; Shin, HS; Song, PH; Yoo, ES; Yoon, JH	1
Kaplan, SA	6
AbdelRazek, M; Abdul Hamid, SK; Bakkar, S; Hasanain, A; Nafee, A; Orabi, H; Safwat, AS; Sayed, M; Shahat, A	1
Dai, Y; Jiann, BP; Li, H; Li, P; Lou, Y; Park, HJ; Viktrup, L; Ye, Z; Zhang, X; Zhang, Z	1
Kitta, T	1
Bae, JH; Choi, H; Kim, JH; Kwon, SS; Park, JY; Shim, JS	1
Krishnappa, P; Moncada, I	1
Blau-Most, M; Geffen, N; Mimouni, M; Segal, O; Segev, F	1
Bi, J; Jiang, Y; Lin, Y; Wei, N; Xue, Z	1
Andrade, C	1
Griebling, TL	1
Kubono, S; Kuramoto, K; Mizutani, H; Takahashi, H; Tanaka, N; Taneyama, T; Yoshida, M	1
Bell, CM; Campbell, ELP; Campbell, RJ; El-Defrawy, SR; Gill, SS; Hooper, PL; Ten Hove, MW; Whitehead, M	1
Bhatia, S; Clode, H; Sullivan, T	1
De Wachter, S; Foley, S; Huang, M; Rees, J; Rosa Arias, J; Skoumal, R; Walters, C; Yavuz, Y	1
Bae, JH; Cheon, J; Choi, H; Jeon, BJ; Park, JY; Tae, BS	1
Cai, T; Cui, Y; Ding, R; Gao, Z; Wu, J; Zhou, Z	1
Andrew, R; Kao-Yang, YH; Lai, EC; MacDonald, TM; Walker, BR; Wei, L	1
Miernik, A; Praus, F	1
Alyaev, YG; Demidko, YL; Fiev, DN; Glybochko, PV; Kopylov, PY; Rapoport, LM; Syrkin, AL; Tsarichenko, DG; Vinarov, AZ	1
Milicevic, S	2
Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M	1
Cho, JY; Jang, IJ; Kim, BH; Kim, JR; Kim, MG; Lim, KS; Shin, SG; Yu, KS	1
Jørgensen, JS; Norregaard, JC; Storr-Paulsen, A; Thulesen, J	1
Abdullah, A; Elghamrawy, H; Elsaied, WM; Salaheldin, M; Shelbaia, A	1
Andrew, R; Cobice, DF; Homer, NZ; Hughes, KA; Naredo, G; Stewart, LH; Upreti, R; Walker, BR	1
Gotoh, M; Masumori, N; Nishizawa, O; Takahashi, S; Takeda, M; Yoshida, M	1
Araki, M; Araki, T; Monden, K	1
El-Gamal, OM; Elbendary, M; Soliman, MG; Taha, MR; Tawfik, A	1
Carrillo-Ruiz, JD; González-Valle, JC; Guzman-Esquivel, J; Labra-Salgado, IR; Maldonado-Ávila, M; Manzanilla-García, HA; Rosas-Nava, E; Sierra-Ramírez, JA	1
Byun, SS; Kim, KH; Lee, JY; Lee, SH; Lee, SJ	1
Barkin, J; Brotherton, BJ; Castro, R; Emberton, M; Roehrborn, CG; Tubaro, A; Wilson, TH	1
Mandal, AK; Mete, UK; Singh, DV; Singh, SK	1
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG; Skeldon, SC	1
Filson, CP; Hollingsworth, JM; Wei, JT	1
Chae, HJ; Choi, BR; Kim, DS; Kim, HK; Park, JK; Zhao, C	1
Campbell, JR; Chang, DF; Colin, J; Schweitzer, C	1
Nicula, C; Nicula, D; Popescu, R	1
Argirović, A; Argirović, D	1
Choi, JY; Park, T	1
Chang, DF; Doss, EL; Potter, MB	1
Baygani, SK; Giuliano, F; Melby, T; Oelke, M; Sontag, A	1
Cooney, TM; Elner, VM; Hood, CT; Hussain, MT; Shtein, RM	1
Ammi, M; Azzouzi, AR; Bigot, P; Cornu, JN; Descazeaud, A; Lebdai, S; Mathieu, R	1
Caiwen, W; Changxiao, H; Shibing, Y; Zhengyong, Y	1
Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F	1
Choo, SH; Han, DH; Kim, JJ; Lee, SW; Sung, HH	1
Gao, ZW; Li, HB; Ren, XQ; Shang, YF; Shao, CS; Xiao, F; Xin, SY; Zhang, JG; Zhang, W	1
Castro, R; D'Ancona, C; Manyak, M; Oelke, M; Roehrborn, CG; Wilson, TH	1
Kara, O; Yazici, M	1
Aharony, S; Corcos, J; Lam, O	1
Chapple, C; Drake, MJ; Drogendijk, T; Klaver, M; Oelke, M; Sokol, R; Traudtner, K; Van Kerrebroeck, P	1
Chang, PL; Chen, CL; Hou, CP; Juang, HH; Lin, YH; Tsai, YL; Tsui, KH	1
Choi, H; Doo, SW; Kim, JH; Kim, JM; Kwon, SS; Lee, HJ; Lim, IS; Song, ES; Song, YS; Sun, HY; Yang, WJ; Yoo, BW; Yoon, JH	1
Ivanovskaya, M; Kosilov, K; Kosilova, L; Loparev, S	1
Ahmed, AF; Gabr, AH; Ghobish, A; Maarouf, A; Shahin, A; Shalaby, E	1
Allegro, R; Arnone, S; Blefari, F; Carini, M; Cimino, S; Collura, Z; Fragalà, E; Gentile, M; Giannantoni, A; Ginepri, A; Minervini, A; Morgia, G; Palmieri, F; Pareo, RM; Russo, GI; Salvia, G; Santelli, G; Vespasiani, G; Voce, S	1
Ho, CH; Hsiao, CH; Liao, CH; Wang, HY; Wang, JJ; Wu, CC	1
Fukuta, F; Ichihara, K; Iwasawa, A; Masumori, N; Tanaka, Y; Tsukamoto, T	1
Bitros, E; Geitona, M; Karabela, P; Katsoulis, IA; Kousoulakou, H; Lyberopoulou, E; Papanicolaou, S; Xaplanteris, L	1
Chung, BH; Hong, S; Kim, CS; Kim, DK; Kim, JC; Lee, JG; Lee, KS; Lee, YS; Park, CH; Park, JK	1
Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA	1
Kozhimannil, KB; Law, MR; Majumdar, SR; Skeldon, SC	1
Bae, JH; Bae, MY; Choi, H; Hwang, SD; Kim, HJ; Kim, JH; Kim, KH; Lee, WJ; Shim, SR; Yoon, SJ	1
Bulbul, E; Ermis, SS; Erol, MK; Koç, A; Koytak, A; Sari, E; Sari, ES; Yazici, A	1
Crosby, RD; Drogendijk, T; Hakimi, Z; Klaver, M; Mathias, SD; Nazir, J; Odeyemi, IA	1
Altay, AB; Apaydin, E; Bademkiran, F; Cikili, N; Semerci, MB; Turna, B; Umul, M	1
De Nunzio, C; Tubaro, A	1
Brotherton, B; Calomfirescu, N; Manyak, MJ; Oyarzabal Perez, I; Palacios, JM; Roehrborn, CG; Roos, EP; Vasylyev, A; Wang, F	1
Ahn, SH; Choi, JD; Kim, JH; Lim, SW; Ryu, YW	1
Graybill, SD; Vigersky, RA	1
Dimitropoulos, K; Gravas, S	1
Coyne, K; Dorey, J; Drake, MJ; Hakimi, Z; Klaver, M; Nazir, J; Odeyemi, IA; Oelke, M; Sokol, R; Traudtner, K; van Kerrebroeck, P	1
Bae, JH; Choi, H; Park, JY; Sim, JS	1
Hakimi, Z; Heemstra, L; Ivanescu, C; Nazir, J; van Engen, A	1
Doros, G; Haider, A; Haider, KS; Traish, AM	1
Ivanovskaya, MA; Kosilov, KV; Kosilova, LV; Loparev, SA	1
Deng, D; Dong, W; Gong, M; Gong, Z; Huang, G; Qiu, S; Yuan, R	1
Barkin, J; Berner, T; Diles, D; Franks, B	1
de la Taille, A; Latil, A; Pétrissans, MT; Robert, G; Rouquet, J	1
Angulo, JC	1
Abu-dewan, K; El-Bahnasy, AH; El-enen, MA; El-Tatawy, H; Gameel, T; Hagras, A; Mousa, A; Raheem, AA	1
Dixon, S; Fraser, LA; Hayward, J; Hwang, YJ; McArthur, E; Ordon, M; Welk, B	1
Jang, EY; Kim, KS; Kim, YT; Moon, HS	1
Armarnik, S; Assia, EI; Mimouni, M; Rosen, E; Segev, F	1
Ahmed, AF	1
Choi, BR; Kim, HK; Lee, SW; Park, JK; So, I; Soni, KK; Zhang, LT	1
Aydin, M; Balci, MB; Hazar, AI; Kalkanli, A; Karaca, AS; Nuhoglu, B; Tandogdu, Z	1
Cui, XJ; Wang, FF; Wang, J; Wang, ZG; Xiao, Y	1
Arai, Y; Chiba, K; Horiuchi, S; Moriyama, S; Noro, A; Saito, K; Takeshita, H; Washino, S	1
Alcaraz, A; Baena-González, V; Brenes-Bermúdez, FJ; Carballido-Rodríguez, J; Cózar-Olmo, JM; García-Rojo, D; Manasanch, J; Medina-López, R; Rodríguez-Rubio, F; Ruiz-Cerdá, JL; Unda-Urzaiz, M	1
Chang, IH; Hwang, SD; Kim, JH; Kim, KH; Shim, SR; Shin, IS; Song, YS; Yoon, SJ	1
Wen, W; Xia, S; Zhong, C	1
Bae, SR; Cho, SY; Han, CH; Hur, KJ; Kim, HW; Kim, SH; Lee, KW; Lee, YS; Park, BH	1
Cao, Y; Chen, T; Guo, L; Niu, H; Wang, Y; Yang, X	1
Brotherton, B; Calomfirescu, N; Manyak, MJ; Oyarzabal Perez, I; Palacios, JM; Roehrborn, CG; Roos, EP; Vasylyev, A	1
Adewole, DA; Nnabugwu, II; Ofoha, CG; Udeh, EI	1
Daneshmand, S; Shamie, N; Zhang, Y	1
Adamo, EB; Altavilla, D; Crea, G; Irrera, N; Lorenzini, C; Marini, H; Micali, A; Minutoli, L; Pisani, A; Puzzolo, D; Rinaldi, M; Squadrito, F; Valenti, A	1
Ito, N; Kamiyama, Y; Kanamaru, S; Kawakita, M; Matsumoto, K; Muguruma, K; Shirahase, T; Takahashi, T; Tsukazaki, H; Tsunemori, H; Utsunomiya, N	1
Fallah-Karkan, M; Hassanzadeh-Hadad, A; Karami, H	1
Cai, JL; Jing, S; Na, YQ; Yan, YF; Yang, Y; Zhou, Z	1
Kosilov, K; Kuzina, I; Lobodenko, A; Loparev, S; Shakirova, O; Zhuravskaya, N	1
Acevedo, A; Ciotkowska, A; Gratzke, C; Hennenberg, M; Herlemann, A; Kan, A; Rutz, B; Stief, CG; Strittmatter, F; Tamalunas, A; Wang, Y; Wiemer, N; Yu, Q	1
Brassetti, A; De Nunzio, C; Esperto, F; Gacci, M; Proietti, F; Serni, S; Tubaro, A	1
Bavendam, T; Carlsson, M; Chancellor, M; Guan, Z; Kaplan, SA; Roehrborn, CG	1
Arikan, G; Bozkurt, O; Demir, O; Durak, I; Esen, A; Saatci, AO; Yaman, A	1
Mamalis, N	2
Cho, MC; Kim, SW; Ku, JH; Paick, JS; Song, SH	1
Schulman, CC	2
Matsumoto, S; Uemura, H	1
Andersson, KE	1
Bechara, A; Casabé, A; Dedola, P; Haime, S; Hernández, C; Rey, H; Romano, S	1
Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Kreder, K; Rovner, ES; Sussman, DO	1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ	1
Richie, JP	1
Chung, BH; Major-Walker, K; Montorsi, F; Morrill, BB; Roehrborn, CG; Siami, P; Wilson, TH	1
Oh-oka, H	1
Bavendam, T; Guan, Z; Kaplan, SA; Kraus, SR; Roehrborn, CG; Wang, JT	1
Barkin, J; Becher, E; Castro, R; Damião, R; Miñana, B; Mirone, V; Montorsi, F; Roehrborn, CG; Siami, P; Wilson, T	1
Braga-Mele, R; Chang, DF; Mamalis, N; Masket, S; Miller, KM; Nichamin, LD; Packard, RB; Packer, M	1
Baena, V; Campoy, P; Carballido, J; Manasanch, J; Ruiz-Cerdá, JL; Slof, J; Unda, M	1
Dragomir, L	1
Fujihara, A; Kamoi, K; Kanazawa, M; Miki, T; Okihara, K; Ukimura, O	1
Moretsky, SL	1
Barkin, J; Black, L; Haillot, O; Montorsi, F; Morrill, B; Roehrborn, CG; Siami, P	1
Anand, N; Chugh, A; Gupta, JB; Gupta, S; Hegde, LG; Jain, S; Malhotra, S; Nanda, K; Naruganahalli, KS; Ray, A; Sinha, N; Tiwari, A	1
Alcaraz, A; Castro, R; Desgrandchamps, F; Hammerer, P; Montorsi, F; Schröder, F	1
Chang, CH; Huang, SW; Wang, CJ	1
Hoyano, Y; Kobayashi, M; Kobayashi, S; Tatemichi, S; Tomiyama, Y; Yamazaki, Y	1
Angelilli, A; De Moraes, CG; Liebmann, JM; Palmiero, PM; Prata, TS; Ritch, R; Sbeity, Z	1
Anderson, GM; Bell, CM; Bronskill, SE; Cernat, G; Fischer, HD; Gill, SS; Gruneir, A; Hatch, WV; Paterson, JM; Rochon, PA	1
Friedman, AH	2
Egawa, S; Hatano, T; Ikemoto, I; Kagami, Y; Kira, S; Mizuo, T; Nakajo, H; Tomita, M	1
Hanai, T; Iguchi, M; Kato, Y; Matsumoto, S; Shouji, S; Tang, XY; Terachi, T; Uemura, H; Usui, Y	1
Gavin, MP; Lockington, D	1
Bassi, PF; Brescia, A; Gardi, M; Pinto, F; Racioppi, M; Sacco, E; Totaro, A; Volpe, A	1
Chang, DF	1
Miller, J; Tarter, TH	1
Furuya, R; Iwasawa, A; Masumori, N; Mori, M; Sonoda, T; Tsukamoto, T	1
Endo, Y; Narita, M; Tsukamoto, T	1
Geng, H; Wu, ZL	1
Byun, SS; Doo, SH; Ha, SB; Hong, SK; Jeong, SJ; Kang, MY; Lee, SE; Min, GE; Park, HJ; Yoon, CY	1
Fink, HA; Garimella, PS; Macdonald, R; Wilt, TJ	1
Barkin, J; Damião, R; Gagnier, RP; Major-Walker, K; Montorsi, F; Morrill, BB; Nandy, I; Roehrborn, CG; Siami, P	1
Chen, W; Dong, Z; Gao, W; Liu, Y; Wang, Z; Yang, K	1
Kadekawa, K; Miyazato, M; Mukouyama, H; Nishijima, S; Sugaya, K	1
Becher, E; Gagnier, RP; Montorsi, F; Roehrborn, CG; Siami, P; Wilson, TH	1
Chang, HS; Chung, BH; Hong, SJ; Kim, CS; Kim, DK; Kim, JC; Lee, JG; Lee, KS; Park, CH; Park, JK	1
Honda, S; Iwata, S; Kawachi, Y; Maruyama, O; Noto, K; Sakurai, T; Sugimura, S	1
Kou, M; Lan, XX; Ren, RM	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Altan-Yaycioglu, R; Yaycioglu, O	1
Chang, DF; Destafeno, JJ; Kim, T; Proia, AD; Santaella, RM; Stinnett, SS	1
Homma, Y; Kawabe, K; Takeda, M; Yoshida, M	1
Arrosagaray, P; Black, L; Geboers, A; Henkel, T; Mirone, V; Montorsi, F; Morrill, B	1
Bhandari, A; Chen, AA; Kelly, JP; Wu, MC	1
Kayes, O; McLoughlin, J	1
Chung, BH; Lee, SH; Mah, SY; Park, KK	1
Hisamatsu, H; Yamashita, S	1
Charles, NC	1
Han, Y; Ku, TK; Naseri, A; Porco, TC; Rutar, T	1
Fujii, N; Miyakita, H; Onodera, Y; Tojo, T; Tokunaga, M; Utsunomiya, T; Yanada, S; Yokoyama, E	1
Dianat, S; Djavan, B; Handl, MJ	1
Inadome, A; Masunaga, K; Nagata, T; Yoshida, M; Yoshiyasu, T	1
Gravas, S	1
Hanyu, S; Hatano, A; Nishiyama, T; Obara, K; Takahashi, K	1
Booth, A; Sheehan, W	1
Andriole, GL; Castro, R; Rittmaster, RS; Roehrborn, CG; Wilson, TH	1
Chapple, CR; Fernández Fernández, E; Koldewijn, E; Montorsi, F; Tammela, TL; Wirth, M	1
Carifi, G	1
González Martín-Moro, J; Munoz-Negrete, FJ; Sanz, FG	1
Bid, HK; Chaudhary, P; Konwar, R; Manchanda, PK; Nayak, VL; Singh, V	1
Mullen, K	1
Bo, JJ; Gu, WD; Leng, J; Liu, DM; Lü, JW; Sun, YM	1
Belavic, JM	1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H	1
Antoñanzas, F; Brenes, F; Cozar, JM; Fernández-Pro, A; Huerta, A; Molero, JM; Palencia, R	1
Fujii, T; Fukumoto, K; Hara, R; Jo, Y; Miyaji, Y; Nagai, A; Sone, A; Yokoyama, T	1
Horvath, K; Vultur, F	1
Miñana, B	1
Barkin, J; Gagnier, RP; Morrill, BB; Roehrborn, CG; Siami, P; Tubaro, A; Wilson, TH	1
Chrisafis, M; Chrisofos, M; Deliveliotis, C; Koritsiadis, S; Papatsoris, AG; Simaioforidis, V	1
Krome, S	1
Alimi, JC; Borre, M; Gagnier, P; Garcia-Penit, J; Montorsi, F; Roehrborn, C; Roeleveld, TA; Wilson, TH	1
Ji, JT; Liu, ZY; Shao, Y; Sun, YH; Wu, YY; Xu, CL; Zhang, LM; Zhang, ZS	1
Atahan, Ö; Budak, YU; Karadağ, E; Öner, S	1
Chantada, V; Fraga, A; Gagnier, P; Haillot, O; Höfner, K; Maciukiewicz, P; Morrill, B; Pushkar, D; Tammela, T	1
Woo, H	1
Chung, BH; Hong, SJ; Kang, SG; Kim, CS; Kim, DK; Kim, JC; Lee, JG; Lee, KS; Park, CH; Park, JK	1
Cheng, CL; Cheng, HL; Chiang, PH; Lin, AT; Tsui, KH; Wu, HC; Wu, TT; Yang, SS; Yu, HJ	1
Baba, S; Fujita, T; Hayakawa, K; Ishiyama, H; Kimura, M; Kitano, M; Kotani, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H	1
Kageyama, S; Ozono, S; Watanabe, T	1
Jin, J; Wan, B; Wang, X; Yang, Y; Ye, H; Yu, W; Zhang, K; Zhang, N; Zhong, C	1
Korstanje, C; Krauwinkel, W; van Doesum-Wolters, FL	1
Hyun, JS; Kim, KT; Kim, SW; Lee, SW; Moon, du G; Moon, KH; Park, JK; Park, K; Park, NC; Son, H; Song, SH	1
Hayashi, Y; Imura, M; Kiniwa, M; Kohri, K; Kojima, Y; Kubota, Y; Oda, N; Sasaki, S	1
Fukuhara, S; Higashino, M; Hirai, T; Kanno, N; Kiuchi, H; Miura, H; Miyagawa, Y; Nakamura, Y; Nakayama, J; Nishimura, K; Nonomura, N; Okuda, H; Takao, T; Tsujimoto, Y; Tsujimura, A; Ueda, T; Yamamoto, K	1
Baker, TM; Bjerklund Johansen, TE; Black, LK	1
Chung, BH; Chung, MS; Lee, SH; Park, KK; Yoo, SJ	1
Hayashi, Y; Imura, M; Kohri, K; Kojima, Y; Kubota, Y; Sasaki, S	1
Ghosh, A; Hazra, A; Kundu, A; Sengupta, G	1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW	1
Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Sasamata, M; Sato, S; Taguchi, K; Ukai, M; Yuyama, H	1
Achtsidis, V; Fountas, KN; Komninos, C; Tentolouris, N; Theodoropoulou, S; Theodossiadis, PG	1
Cox, D; Giuliano, F; Mirone, V; Oelke, M; Viktrup, L; Xu, L	1
Hashim, H; Ismail, M	1
Chapple, CR	3
Black, LK; Roehrborn, CG; Wilson, TH	1
Bansal, N; Gupta, S; Sharma, A	1
Carini, M; Gacci, M; Lapini, A; Maggi, M; Rossetti, MA; Serni, S; Siena, G; Tosi, N; Vignozzi, L; Vittori, G	1
Keating, GM	1
Allona, A; Angulo, J; Cuevas, P; Fernández, A; La Fuente, JM; Moncada, I; Sáenz de Tejada, I	1
Chung, BH; Lee, SH; Major-Walker, K; Montorsi, F; Roehrborn, CG; Siami, PF; Wilson, TH	1
Bhattachan, CL; Bhomi, KK	1
Bijelic, R; Milicevic, S	1
Cantemir, A; Chiseliţă, D; Epifanov, L; Huţuleac, A; Irod, A	1
Aminsharifi, A; Hadi, N; Sadeghi, A; Tourchi, A	1
Imaoka, T; Kim, SC; Morisaki, Y; Viktrup, L; Wang, CJ; Yokoyama, O; Yoshida, M	1
Gacci, M	1
Horita, H; Masumori, N; Miyao, N; Sato, E; Sunaoshi, K; Takeyama, K; Tanaka, Y; Tsukamoto, T	1
Botto, H; Camparo, P; Gilles, N; Guérard, M; Guilloteau, V; Lluel, P; Maiga, A; Palea, S; Rekik, M; Rischmann, P; Rouget, C	1
Artibani, W; Chapple, CR; Montorsi, F; Novara, G; Sanseverino, R; Spatafora, S; Tubaro, A; Zattoni, F	1
Lee, LM; Lin, KH; Lin, YW; Wen, YC	1
Lee, HJ; Lee, JW	1
Cerqueira, JB; de Moraes, MO; Jamacaru, FV; Josino, IR; Nogueira, EA; Regadas, RP; Reges, R; Silva, LF; Sucupira, DG	1
Ashida, S; Fujioka, T; Inoue, K; Kohri, K; Kojima, Y; Kubo, M; Matsuda, K; Miki, T; Nakamura, Y; Obara, W; Ohnishi, Y; Okihara, K; Sasaki, S; Shuin, T; Sugimura, J; Takaha, N; Takata, R; Tanikawa, C; Yamaguchi, M	1
Bae, JH; Kim, JH; Kwon, SS; Lee, JG; Oh, MM; Park, JY	1
Andreadakis, S; Konstantinidis, C; Samarinas, M; Skriapas, K; Xanthis, S	1
Ding, H; Du, W; Hou, ZZ; Wang, HZ; Wang, ZP	1
Akin, Y; Gulmez, H; Ucar, M; Yucel, S	1
Matthies, AK; Tachikawa, NJ	1
Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J	1
Cox, D; Giuliano, F; Hatzimouratidis, K; Jungwirth, A; Oelke, M; Viktrup, L; Watts, S	1
Doyle, S; Hunjan, M; Posnett, J; Walker, A	1
Botoca, M; Bucuras, V; Cumpanas, AA; Minciu, R	1
Ashitomi, K; Hatano, T; Miyazato, M; Nishijima, S; Ogawa, Y; Sugaya, K	1
Bahnson, RR; Dull, P; Reagan, RW	1
Belussi, D; Borgonovo, G; Deiana, G; Lembo, A; Levorato, CA; Ranieri, A; Sironi, D	1
Boyle, P; Da Silva, FC; Debruyne, F; Gillenwater, JG; Hamdy, FC; Koch, G; Perrin, P; Raynaud, JP; Teillac, P; Vela-Navarrete, R	2
Billebaud, T; Coulange, C; Gattegno, B; Glemain, P; Loeb, G; Muszynski, R	1
Mac Donald, R; Rutks, I; Wilt, TJ	1
Shishido, K; Yokota, T	1
Kirby, RS	1
Koraev, KN	1
Arai, Y; Ichioka, K; Matsui, Y; Ohara, H; Terada, N; Terai, A; Yoshimura, K	2
Athanasopoulos, A; Barbalias, G; Fisfis, J; Giannitsas, K; Gyftopoulos, K; Perimenis, P	1
Evans, CP; Moon, T; Narayan, P	1
Djavan, B	1
Nickel, JC	1
Bakken, E; Cornélissen, G; Halberg, F; Katinas, G; Maggioni, C; Otsuka, K; Perfetto, F; Schwartzkopff, O; Tarquini, R	1
Romics, I	1
Chen, SG; Hua, LX; Qian, LX; Sui, YG; Wu, HF; Xu, ZQ; Zhang, W	1
Abe, K; Goto, H; Ikemoto, I; Kishimoto, K; Kiyota, H; Miki, K; Ohishi, Y	1
de Graaf, L; de Graff, L; Lijnen, RL	1
Brausi, M; Porru, D; Rigatti, P; Rizzi, CA; Scarpa, RM; Schumacher, H	1
de la Rosette, JJ; Michel, MC	1
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C	1
Jensen, D; Kirby, RS; Mallen, S; Quinn, S	1
Boyle, P; Calais Da Silva, F; Debruyne, F; Gillenwater, JG; Hamdy, FC; Perrin, P; Raynaud, JP; Schulman, CC; Teillac, P; Vela-Navarrete, R	1
Doggrell, SA	1
Espinosa, FJ; Hernández, C; Marqués, A; Palacio, A; Prats, J	1
Gerber, GS; Gong, EM	1
Boyle, P; Calais da Silva, F; Debruyne, F; Gillenwater, JG; Hamdy, FC; Perrin, P; Raynaud, JP; Schulman, C; Teillac, P; Vela-Navarrete, R	1
Bennato, R; D'Agostino, L; Manguso, F; Scaramuzzo, A	1
Auerbach, SM; Cihon, F; Gittelman, M; Mazzu, A; Sundaresan, P; White, WB	1
Barnett, G; Brown, CT; Ellis, BW; Emberton, M; Ryan, M; Watson, V	1
Mazo, EB; Shashin, MN	1
Lowe, FC	1
Lucas, MG; Nargund, V; Stephenson, TP	1
Desgrandchamps, F; Fitzpatrick, JM	1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E	1
Nordling, J	1
Doi, T; Hashimoto, T; Iwata, M; Nagabukuro, H	1
Carlson, AM; Naslund, MJ; Williams, MJ	1
Busse, M; Gross, AJ; Leonard, J; Schumacher, H	1
Campbell, JR; Chang, DF	1
Muzzonigro, G	1
Raynaud, JP; Schulman, CC; Teillac, P; Zlotta, AR	1
Anand, JS; Chodorowski, Z; Wiśniewski, M	1
Gotoh, M; Kamihira, O; Kinukawa, T; Ohshima, S; Ono, Y; Origasa, H	1
Wyllie, MG	1
Pärssinen, O	1
Athanasopoulos, A; Perimenis, P	1
Bylsma, GW; Lawrentschuk, N	1
Nguyen, DQ; Philip, J; Sebastian, RT	1
Furuya, R; Furuya, S; Hisasue, S; Itoh, N; Masumori, N; Ogura, H; Tsukamoto, T	1
Egilmez, T; Guvel, S; Kilinc, F; Ozkardes, H; Pourbagher, MA; Turunc, T	1
Irani, J	1
Burnett, AL; Wein, AJ	1
Kershner, RM	1
Packard, R; Pringle, E	1
Kyle, G; Nguyen, DQ; Sebastian, RT	1
Claoué, C; Parmar, B; Qatarneh, D	1
Giuliano, F	1
Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Yamamoto, H	1
Kawabe, K	3
Hayashi, M; Kobayashi, M; Kobayashi, S; Shibata, N; Tadachi, M; Tatemichi, S; Tomiyama, Y; Yamazaki, Y	1
de la Rosette, JJ; Michel, MC; van Dijk, MM	1
Deguchi, T; Ishihara, S; Masue, T; Miwa, K; Nishino, Y; Takahashi, Y	1
Tiwari, A	1
Homma, Y; Kawabe, K; Kubota, K; Sozu, T	1
O'Leary, MP	2
Kobayashi, M; Morita, T; Tokue, A	1
Davidai, G; Flannery, MT; Ramsdell, J; Ranhosky, A; Ruoff, G	1
Aslan, G; Esen, A; Koseoglu, H; Ozdemir, I	1
Shugar, JK	2
Awan, MA; Cheung, CM; Sandramouli, S	1
Akiyama, K; Kobayashi, M; Tatemichi, S; Uruno, T; Yamazaki, Y; Yokoyama, O	1
Kobayashi, K; Kobayashi, M; Kobayashi, S; Maezawa, A; Maruyama, I; Shibata, N; Tatemichi, S; Tomiyama, Y; Yamazaki, Y	1
Dugué, B; Keski-Rahkonen, P; Lehtonen, M; Leppänen, E; Mauriala, T; Pärssinen, O	1
Bertero, E; Cairoli, CE; DA Ros, CT; Damião, R; Koff, WJ; Mesquita, F; Pinheiro, GE; Pompeo, AC; Rosenblatt, C; Wroclawski, ER	1
Homma, Y; Kawabe, K; Yoshida, M	1
Cheng, YH; Gao, ZW; Ren, XQ; Wang, YL; Zhang, JG	1
Awa, Y; Egoshi, K; Furuya, Y; Hamano, S; Ichikawa, T; Mikami, K; Nakatsu, H; Ohki, T; Okano, T; Ota, S; Suzuki, H; Yano, M	1
Bendel, RE; Phillips, MB	1
Allen, D; Manvikar, S	1
Frost, A; Lim, LA	1
Cho, TW; Hong, YK; Jang, WK; Lee, YK; Lee, YT; Park, DS	1
Allen, D; Packard, R	1
Birowo, P; Djati, W; Rahardjo, D; Soebadi, DM; Sugandi, S; Wahyudi, I	1
Kähönen, M; Kööbi, T; Nieminen, T; Tammela, TL	1
Bavendam, T; Carlsson, M; Guan, Z; Kaplan, SA; Roehrborn, CG; Rovner, ES	1
Knottnerus, JA; Norg, RJ; Portegijs, PJ; van de Beek, K; van Schayck, CP	1
Fujita, Y; Inamura, M; Koyama, T; Miyoshi, T; Ohashi, Y; Ohki, K; Okamoto, S; Oshika, T; Sakabe, I; Takahashi, K; Yasuma, T	1
Hizli, F; Uygur, MC	1
Flach, A; Lee, SE; McCaffery, S; O'Brien, JM; Petrovic, V; Shapiro, BL	1
Ding, Q; He, Z; Wang, J; Xu, K; Xue, Z; Zhang, Y	1
Borooah, S; Chadha, V	1
Osher, RH	1
Subramonian, K; Young, JG	1
Amarshi, N; Bell, WA	1
Adibelli, FM; Akova, YA; Altan-Yaycioglu, R; Gul, U; Pelit, A; Yaycioglu, O	1
Herd, MK	1
Hosokawa, Y; Kishino, T; Momose, H; Ono, T; Oyama, N	1
Istad, JA; Johansen, TE	1
Chan, DG; Figueira, EC; Francis, IC; Lee, KJ; Masselos, K; Ooi, JL; Sharma, NS	1
Awan, MA; Cheung, CM; Peh, KK; Sandramouli, S	1
Can, I; Takmaz, T	1
Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S	1
Ku, JH; Song, YS	1
Inadome, A; Maeda, Y; Masunaga, K; Nagata, T; Satoji, Y; Sugiyama, Y; Yoshida, M	1
Abrams, P; Barendrecht, MM; de la Rosette, JJ; Michel, MC; Schumacher, H	1
Barqawi, AB; Crawford, ED; Myers, JB; O'Donnell, C	1
Abe, K; Egaway, S; Furuta, A; Ikemoto, I; Kishimoto, K; Kiyota, H; Kosugi, S; Shimomura, T; Shirai, H; Suzuki, Y; Takeuchi, H; Torii, S	1
Hasan, M; Kibria, MD; Parveen, F; Shamsuzzaman, AK	1
Barkin, J; Damiao, R; Duggan, A; Major-Walker, K; Morrill, BB; Roehrborn, CG; Siami, P; Wyczolkowski, M	1
Backhouse, OC; Brogden, PR; Saldana, M	1
Gallenga, PE; Lobefalo, L	1
Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ	1
Bartsch, G; Frauscher, F; Herwig, R; Mitterberger, M; Pallwein, L; Pinggera, GM; Schuster, A; Strasser, H	1
Barkin, J; Damião, R; Major-Walker, K; Montorsi, F; Morrill, B; Roehrborn, CG; Siami, P	1
Hayase, M; Hayashi, Y; Kohri, K; Kojima, Y; Kubota, Y; Sasaki, S; Shinoura, H; Tsujimoto, G	1
Hirayama, H; Ishimatsu, T; Ogata, I; Seo, H; Tsuruda, A; Tsuzaki, S; Yamasaki, K	1
Bálint, J; Demeter, A; Egri, G; Fogassy, E; Gizur, T; Greiner, I; Törley, J	1
Grey, AD; Nargund, VH	1
Rich, KT; Safranek, S	1
Gunasekera, V; Kashani, S; Sallam, A; Toma, M	1
Drescher, P; Eckert, RE; Madsen, PO	1
Honda, K; Inagaki, O; Kawabe, K; Kimura, R; Mori, R; Ohkura, T; Tanaka, C; Yamada, S	1
Geller, J; Kirchenbaum, A; Lepor, H; Levine, AC	1
Abrams, P; Schulman, CC; Vaage, S	1
Breslin, D; Chou, TC; Felsen, D; Fields, DW; Kane, M; Marion, DN; Vaughan, ED	1
Asano, M; Fujikura, T; Honda, K; Niigata, K; Takenaka, T	1
Cortvriend, J; Jonas, U; Lock, TM; Schulman, CC; Speakman, MJ; Vaage, S	2
Abrams, P; Boeminghaus, F; Chapple, CR; Nordling, J; Wyndaele, JJ; Ypma, AF	1
Sakai, S; Shimazaki, J	1
Hamada, K; Kawabe, K; Kurimoto, S; Moriyama, N; Taniguchi, J	1
Chen, J; Chueh, SC; Guh, JH; Ko, FN; Lai, MK; Teng, CM	1
Esa, A; Kiwamoto, H; Koike, H; Kurita, T; Miyatake, R; Ohnishi, N; Park, YC; Sugiyama, T	1
Fujita, K; Kawabe, K; Kurita, Y; Suzuki, K; Ushiyama, T	1
Arakawa, S; Kamidono, S; Kawaida, N; Matsumoto, O; Ogawa, T; Okada, H	1
McTavish, D; Wilde, MI	1
Brune, ME; Buckner, SA; Hancock, AA; Ireland, LM; Katwala, SP; Kerwin, JF; Milicic, I	1
Morita, M; Numahata, K; Ogata, Y; Suzuki, K	1
Fujita, K; Kawabe, K; Kurita, Y; Masuda, H; Suzuki, K	1
Hashimoto, T; Hayami, S; Ichiyanagi, O; Ishigooka, M; Nakada, T; Suzuki, Y	1
Akiyama, K; Ishida, N; Kawabe, K; Moriyama, N; Murata, S; Taniguchi, J; Yamazaki, S	1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I	1
Buzelin, JM; Fonteyne, E; Khan, A; Kontturi, M; Witjes, WP	1
Abrams, P; Arkell, D; Pocock, R; Speakman, M; Stott, M	1
Lee, C; Lee, E	1
Baert, L; Chapple, CR; Höfner, K; Khoe, GS; Spångberg, A; Thind, P	1
Katsumi, T; Kawaguchi, K; Murayama, K; Tajika, E; Ueki, O	1
Beduschi, MC; Beduschi, R; Oesterling, JE	2
Kawabe, K; Kimura, R; Ohkura, T; Yamada, S	1
Lepor, H	2
de Mey, C; McEwen, J; Michel, MC; Moreland, T	1
Bressel, HU; Goepel, M; Mehlburger, L; Michel, MC; Schäfers, RF; Schumacher, H	1
de Mey, C	2
Bressel, HU; Goepel, M; Mehlburger, L; Michel, MC	1
Asari, T; Egawa, M; Haginaka, T; Kameda, K; Katsumi, T; Kawaguchi, K; Miyazaki, K; Murayama, K; Nishino, A; Sakai, A; Ueki, O	1
Narayan, P; Tewari, A	1
Flannery, M; Lowenthal, DT; Mader, SL; Nelson, RP	1
Narayan, P	1
Bèïque, L; Evans, MF; Por, CP	1
Djavan, B; Fakhari, M; Ghawidel, K; Marberger, M; Partin, AW; Roehrborn, CG; Seitz, C; Shariat, S	1
Basharkhah, A; Bursa, B; Djavan, B; Ghawidel, K; Hruby, S; Marberger, M	1
Claes, H; De Reijke, TM; Folkestad, B; Höfner, K; Speakman, MJ	1
Akiyama, K; Hora, M; Kitazawa, M; Masuda, N; Nakamura, S; Tatemichi, S; Yamagishi, R	1
Gu, FL; Guo, YL; Na, YJ	1
Lee, TH	1
Douno, S; Emoto, A; Kasagi, Y; Li, W; Mimata, H; Mori, H; Nomura, Y; Satoh, F	1
Akimoto, M; Hattori, T; Horiuchi, K; Tsuboi, N; Yoshida, K	1
Lee, M	1
Hirao, Y; Kamidono, S; Kishimoto, T; Kurita, T; Okada, H; Okajima, E; Okuyama, A; Ozono, S; Park, Y; Yamamoto, K; Yoshioka, T	1
Bressel, HU; Goepel, M; Mehlburger, L; Michel, MC; Schumacher, H	1
Tsujii, T	1
Clifford, GM; Farmer, RD	1
Benning, CM; Chon, J; Kyprianou, N	1
Caprino, L	1
Goepel, M; Mehlburger, L; Michel, MC; Neumann, HG; Schumacher, H	1
Akaza, H; Kikuchi, K; Koiso, K; Kondo, F; Noguchi, R; Ohtani, M; Tsuchiya, A	1
Fujioka, T; Goto, Y; Isurugi, K; Katoh, T; Numasato, S; Obara, W; Omori, S; Suzuki, Y	1
Ganev, T; Kotzev, R; Kumanov, H; Mladenov, D; Nikolov, S; Penkov, R; Petkova, L; Stratev, S; Uzunov, A; Uzunov, N	1
Lepor, H; Narayan, P	1
De la Rosette, JJ; Farmer, RD; Herings, RM; Leufkens, HG; Man in 't Veld, AJ; Souverein, PC	1
Mann, RD; Pearce, G; Shakir, S	1
Bressel, HU; Goepel, M; Michel, MC; Rübben, H	1
Cervenakov, I; Fillo, J	1
Boeminghaus, F; Buzelin, JM; Lock, TM; Schulman, CC; Stephenson, TP; Talja, M	1
Dutkiewics, S	1
Flannery, MT; Michel, MC; Narayan, P	1
MacDonald, R; Nelson, D; Wilt, TJ	1
Bales, GT; Benson, DA; Gerber, GS; Kim, HL; Kim, JC	1
Scarpa, RM	1
Speakman, MJ	1
Jarvis, B; Lyseng-Williamson, KA; Wagstaff, AJ	1
Chess-Williams, R	1
Fujimoto, K; Hayashi, Y; Hirao, Y; Kurumatani, N; Okajima, E; Otani, T; Ozono, S; Yoshida, K	1
Howe, W; MacDonald, R; Wilt, TJ	1
Arai, G; Hayashi, T; Hyochi, N; Kageyama, Y; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Okuno, T; Saito, K; Sakai, Y; Suzuki, M	1
de la Rosette, JJ; Floratos, DL; Kiemeney, LA; Kortmann, BB; Rossi, C; Sonke, GS	1
Dunn, CJ; Faulds, DM; Matheson, A	1
Andersson, KE; Chapple, C	1
Mimata, H; Miyoshi, M; Nomura, Y; Ohno, H; Satoh, F	1
Aoki, A; Baba, Y; Hara, Y; Harada, H; Harada, N; Hashimoto, O; Hayashida, S; Hirao, H; Hironaka, H; Isoyama, R; Jojima, K; Joko, K; Kamiryo, Y; Kato, M; Koshido, Y; Matsuyama, H; Mitsui, H; Nagao, K; Nagata, K; Naito, K; Nasu, T; Otsuka, T; Sacho, T; Shimizu, Y; Shiraishi, K; Suyama, K; Takemoto, M; Tuchida, M; Wada, T; Yamaguchi, M; Yamakawa, G	1
Akino, H; Arai, Y; Fukuyama, T; Hida, S; Okabe, T; Okada, K; Takeuchi, H; Tomoyoshi, T; Yoshida, O	1

Reviews

90 review(s) available for tamsulosin and Adenoma, Prostatic

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997
A systematic, concept-based method of developing the exposure measure for drug safety and effectiveness studies. Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:1 Topics: Humans; Male; Pharmaceutical Preparations; Pharmacoepidemiology; Prostatic Hyperplasia; Research Design; Tamsulosin	2022
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2021, Dec-21, Volume: 93, Issue:4 Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Serenoa; Tamsulosin	2021
Medical Treatment of Benign Prostatic Hyperplasia. The Urologic clinics of North America, 2022, Volume: 49, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin	2022
[Use of tamsulosin for a prevention of acute urinary retention in the perioperative period in patients undergoing to surgical procedures]. Urologiia (Moscow, Russia : 1999), 2023, Issue:4 Topics: Humans; Male; Perioperative Period; Postoperative Complications; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2023
The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis. Medicine, 2020, Volume: 99, Issue:4 Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive	2020
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis. BioMed research international, 2020, Volume: 2020 Topics: Bayes Theorem; Databases, Factual; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Safety; Sildenafil Citrate; Tadalafil; Tamsulosin; Treatment Outcome	2020
Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials. Medical science monitor : international medical journal of experimental and clinical research, 2020, Apr-24, Volume: 26 Topics: Adrenergic alpha-1 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Humans; Hyperplasia; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome	2020
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED. Current urology reports, 2020, Oct-27, Volume: 21, Issue:12 Topics: Combined Modality Therapy; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2020
Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis. Andrologia, 2021, Volume: 53, Issue:9 Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2021
Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis. Medicine, 2021, Aug-20, Volume: 100, Issue:33 Topics: Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urological Agents	2021
[Therapeutic effects of α-adrenergic receptor antagonists on benign prostatic hyperplasia: A network meta-analysis]. Zhonghua nan ke xue = National journal of andrology, 2018, Volume: 24, Issue:3 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoles; Male; Network Meta-Analysis; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological; Tamsulosin	2018
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. The Cochrane database of systematic reviews, 2018, 10-11, Volume: 10 Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents	2018
Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia. BMC urology, 2019, Mar-11, Volume: 19, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tamsulosin; Treatment Outcome	2019
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms]. Der Urologe. Ausg. A, 2019, Volume: 58, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents	2019
Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis. World journal of urology, 2014, Volume: 32, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Azasteroids; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents	2014
[Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2014, Volume: 24, Issue:5 Topics: Humans; Laser Therapy; Male; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urinary Bladder Neck Obstruction; Urinary Retention; Urological Agents	2014
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. The journal of sexual medicine, 2014, Volume: 11, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents	2014
General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis. Current medical research and opinion, 2015, Volume: 31, Issue:2 Topics: Asia; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents	2015
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment. Nature reviews. Urology, 2015, Volume: 12, Issue:2 Topics: Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Drug Combinations; Humans; Laser Therapy; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Solifenacin Succinate; Sulfonamides; Tadalafil; Tamsulosin; Transurethral Resection of Prostate; Urological Agents	2015
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Drug design, development and therapy, 2015, Volume: 9 Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin	2015
Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis. Current medical research and opinion, 2015, Volume: 31, Issue:9 Topics: Drug Monitoring; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Outcome Assessment, Health Care; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Retention; Urological Agents	2015
Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study. Yonsei medical journal, 2016, Volume: 57, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2016
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia. International journal of molecular sciences, 2016, Aug-11, Volume: 17, Issue:8 Topics: Apoptosis; Dutasteride; Endocrine System; Finasteride; Humans; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urological Agents	2016
Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Expert opinion on drug metabolism & toxicology, 2008, Volume: 4, Issue:6 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Cardiovascular Diseases; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug and Narcotic Control; Humans; Intestinal Absorption; Male; Prostatic Hyperplasia; Risk Assessment; Sulfonamides; Tamsulosin; Treatment Outcome	2008
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?]. Harefuah, 2008, Volume: 147, Issue:6 Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2008
Dutasteride (Avodart) with tamsulosin (Flomax) for benign prostatic hyperplasia. The Medical letter on drugs and therapeutics, 2008, Oct-06, Volume: 50, Issue:1296 Topics: Azasteroids; Clinical Trials as Topic; Drug Therapy, Combination; Dutasteride; Erectile Dysfunction; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2008
ASCRS White Paper: clinical review of intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Prostatic Hyperplasia; Pupil; Receptors, Adrenergic, alpha-1; Sulfonamides; Syndrome; Tamsulosin	2008
[Floppy iris syndrome]. Oftalmologia (Bucharest, Romania : 1990), 2008, Volume: 52, Issue:2 Topics: Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Miosis; Phacoemulsification; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2008
A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits. The Prostate, 2009, Jun-01, Volume: 69, Issue:8 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Azasteroids; Dihydrotestosterone; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Testosterone; Urinary Tract Infections	2009
Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2009, Volume: 81, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Age Factors; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Azasteroids; Biomarkers, Tumor; Disease Progression; Dutasteride; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Male; Practice Guidelines as Topic; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; Risk Factors; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2009
Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. Clinical interventions in aging, 2009, Volume: 4 Topics: Aged; Antineoplastic Agents; Azasteroids; Cholestenone 5 alpha-Reductase; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2009
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4 Topics: Adrenergic alpha-Antagonists; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Prostatism; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2009
Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review. Systems biology in reproductive medicine, 2009, Volume: 55, Issue:4 Topics: Adrenergic alpha-Antagonists; Humans; Male; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2009
Efficacy and safety of tamsulosin for the treatment of benign prostatic hyperplasia: a meta analysis. Chinese medical journal, 2010, Jan-20, Volume: 123, Issue:2 Topics: Antineoplastic Agents; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2010
Intraoperative floppy iris syndrome: facts for the urologist. Urology, 2010, Volume: 76, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin; Urology	2010
Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:15 Topics: Animals; Azasteroids; Drug Therapy, Combination; Dutasteride; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome	2010
OTC tamsulosin for benign prostatic hyperplasia. Drug and therapeutics bulletin, 2010, Volume: 48, Issue:10 Topics: Adrenergic alpha-Antagonists; Aged; Counseling; Fees, Pharmaceutical; Humans; Life Style; Male; Middle Aged; Nonprescription Drugs; Practice Guidelines as Topic; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2010
[How effective is finasteride?]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:8 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2011
Dutasteride/tamsulosin: in benign prostatic hyperplasia. Drugs & aging, 2012, May-01, Volume: 29, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Drug Combinations; Dutasteride; Humans; Male; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2012
Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement. World journal of urology, 2013, Volume: 31, Issue:4 Topics: Dose-Response Relationship, Drug; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents	2013
Silodosin is effective for treatment of LUTS in men with BPH: a systematic review. Asian journal of andrology, 2013, Volume: 15, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2013
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2013
Managing benign prostatic hyperplasia. American family physician, 2002, Jul-01, Volume: 66, Issue:1 Topics: Complementary Therapies; Doxazosin; Humans; Male; Palpation; Prostatectomy; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urine	2002
Tamsulosin for benign prostatic hyperplasia. The Cochrane database of systematic reviews, 2003, Issue:1 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Retention	2003
[Alpha 1-adrenoceptor antagonists for treatment of prostatic hyperplsia]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Androgen Antagonists; Drug Therapy, Combination; Humans; Male; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2002
Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life. Urology, 2003, Volume: 62, Issue:3 Suppl 1 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Finasteride; Humans; Male; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Serenoa; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urinary Retention	2003
Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment. Urology, 2003, Volume: 62, Issue:3 Suppl 1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Male; Phytotherapy; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2003
The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia. Urology, 2003, Volume: 62, Issue:3 Suppl 1 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prostatic Hyperplasia; Prostatitis; Radiotherapy; Sulfonamides; Tamsulosin; Urologic Diseases; Urologic Surgical Procedures	2003
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
Efficacy and safety of tamsulosin in the treatment of urological diseases. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Male; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urologic Diseases	2004
Saw palmetto and benign prostatic hyperplasia. The American journal of Chinese medicine, 2004, Volume: 32, Issue:3 Topics: Adrenergic alpha-Antagonists; Androgen Antagonists; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Male; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Serenoa; Sulfonamides; Tamsulosin; Urodynamics	2004
Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clinical therapeutics, 2004, Volume: 26, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Tract; Urologic Diseases	2004
The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia. BJU international, 2005, Volume: 95, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Clinical Trials as Topic; Delayed-Action Preparations; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2005
One drug fits all. BJU international, 2005, Volume: 96, Issue:4 Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Combinations; Drug Industry; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2005
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases	2005
Benign prostatic hyperplasia in primary care: what you need to know. The Journal of urology, 2006, Volume: 175, Issue:3 Pt 2 Topics: Age Distribution; Aged; Aged, 80 and over; Benzhydryl Compounds; Biopsy, Needle; Cresols; Humans; Immunohistochemistry; Incidence; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders	2006
Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU international, 2006, Volume: 97 Suppl 2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Ejaculation; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin	2006
[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126 Spec no. Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Cloning, Molecular; Drug Design; Drug Tolerance; Humans; Male; Molecular Sequence Data; Naphthalenes; Piperazines; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethral Obstruction	2006
[Latest frontiers in pharmacotherapy for benign prostatic hyperplasia]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126 Spec no. Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Design; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethral Obstruction	2006
Effects of alpha(1)-adrenoceptor antagonists on male sexual function. Drugs, 2006, Volume: 66, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Aged; Doxazosin; Ejaculation; Erectile Dysfunction; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2006
Tamsulosin and floppy iris syndrome in benign prostatic hyperplasia patients. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:4 Topics: Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2006
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Clinical Trials as Topic; Delayed-Action Preparations; Female; Female Urogenital Diseases; Humans; Male; Male Urogenital Diseases; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2008
FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia. American family physician, 2008, Mar-01, Volume: 77, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Practice Guidelines as Topic; Prazosin; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome	2008
Therapeutic controversies: clinical treatment of benign prostatic hyperplasia. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:3 Topics: Adrenergic alpha-Antagonists; Cholestenone 5 alpha-Reductase; Clinical Trials as Topic; Drug Therapy, Combination; Finasteride; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Oxidoreductases; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1995
Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia. British journal of urology, 1995, Volume: 76 Suppl 1 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Male; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1995
[Discovery and development of tamsulosin hydrochloride, a new alpha 1-adrenoceptor antagonist]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1995, Volume: 115, Issue:10 Topics: Adrenergic alpha-Antagonists; Animals; Clinical Trials as Topic; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	1995
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. European urology, 1996, Volume: 29, Issue:2 Topics: Adrenergic alpha-Antagonists; Blood Pressure; Clinical Trials as Topic; Doxazosin; Half-Life; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Vasodilation	1996
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. European urology, 1996, Volume: 29, Issue:2 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Europe; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Pulse; Sulfonamides; Tamsulosin; Urination	1996
Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia. Drugs, 1996, Volume: 52, Issue:6 Topics: Adrenergic alpha-Agonists; Clinical Trials as Topic; Delayed-Action Preparations; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1996
[Alpha blockers in the treatment of benign hyperplasia of the prostate]. Revista clinica espanola, 1997, Volume: 197, Issue:5 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1997
Benign prostatic hyperplasia: use of drug therapy in primary care. Geriatrics, 1998, Volume: 53, Issue:3 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Primary Health Care; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade. British journal of urology, 1998, Volume: 81 Suppl 1 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1998
Current status of research on prostate-selective alpha 1-antagonists. British journal of urology, 1998, Volume: 81 Suppl 1 Topics: Adrenergic alpha-Antagonists; Cresols; Humans; Indoles; Male; Muscle, Smooth; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Sulfonamides; Tamsulosin; Treatment Outcome	1998
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist. Urology, 1998, Volume: 51, Issue:6 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: impact on safety and well-being. European urology, 1998, Volume: 34 Suppl 2 Topics: Adrenergic alpha-Antagonists; Blood Pressure; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction	1998
Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH. European urology, 1998, Volume: 34 Suppl 2 Topics: Adrenergic alpha-Antagonists; Blood Pressure; Hemodynamics; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction	1998
Tamsulosin for the treatment of benign prostatic hypertrophy. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:2 Topics: Adrenergic alpha-Antagonists; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2000
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
[Drugs for the treatment of benign prostatic hypertrophy]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2000, Volume: 52, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Androgen Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Muscle, Smooth; Plant Extracts; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Serenoa; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urodynamics	2000
Worldwide experience with alfuzosin and tamsulosin. Urology, 2001, Volume: 58, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Controlled Clinical Trials as Topic; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urodynamics	2001
Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. The Journal of urology, 2002, Volume: 167, Issue:1 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urination Disorders; Urodynamics	2002
Tamsulosin: current clinical experience. Urology, 2001, Volume: 58, Issue:6 Suppl 1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2001
Initial choices and final outcomes in lower urinary tract symptoms. European urology, 2001, Volume: 40 Suppl 4 Topics: Adrenergic alpha-Antagonists; Finasteride; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Retention	2001
Tamsulosin: an update of its role in the management of lower urinary tract symptoms. Drugs, 2002, Volume: 62, Issue:1 Topics: Adrenergic alpha-Antagonists; Animals; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urologic Diseases	2002
The use of alpha-adrenoceptor antagonists in lower urinary tract disease. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:2 Topics: Adrenergic alpha-Antagonists; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urologic Diseases	2002
Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects. BJU international, 2002, Volume: 89, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Drug Combinations; Enzyme Inhibitors; Finasteride; Humans; Male; Patient Dropouts; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urinary Retention; Urination	2002
Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs & aging, 2002, Volume: 19, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder; Urologic Diseases	2002
Tamsulosin: an overview. World journal of urology, 2002, Volume: 19, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Europe; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Treatment Outcome; United States	2002

Trials

201 trial(s) available for tamsulosin and Adenoma, Prostatic

Article	Year
Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial. BMC urology, 2021, Oct-19, Volume: 21, Issue:1 Topics: Aged; Cucurbita; Humans; Iran; Kallikreins; Male; Middle Aged; Plant Oils; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; Single-Blind Method; Tamsulosin; Urination; Urological Agents	2021
The effect of Melatonin on Improving the benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial. Urology journal, 2022, Nov-08, Volume: 19, Issue:5 Topics: Double-Blind Method; Humans; Male; Melatonin; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2022
Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial. International journal of urology : official journal of the Japanese Urological Association, 2022, Volume: 29, Issue:6 Topics: Double-Blind Method; Drug Therapy, Combination; Herbal Medicine; Humans; Lower Urinary Tract Symptoms; Male; Pain; Prospective Studies; Prostatic Hyperplasia; Prostatitis; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2022
Editorial Comment to Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial. International journal of urology : official journal of the Japanese Urological Association, 2022, Volume: 29, Issue:6 Topics: Double-Blind Method; Drug Therapy, Combination; Herbal Medicine; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome	2022
Influence of alpha-adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Lower urinary tract symptoms, 2020, Volume: 12, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Defecation; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Symptom Assessment; Tamsulosin; Treatment Outcome	2020
Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study. Neurourology and urodynamics, 2020, Volume: 39, Issue:1 Topics: Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS). The Journal of urology, 2020, Volume: 203, Issue:6 Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents	2020
Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of International journal of clinical practice, 2020, Volume: 74, Issue:5 Topics: Aged; Double-Blind Method; Dutasteride; Ejaculation; Humans; Libido; Lower Urinary Tract Symptoms; Male; Men's Health; Middle Aged; Penile Erection; Prospective Studies; Prostatic Hyperplasia; Sexual Behavior; Sexual Health; Surveys and Questionnaires; Tamsulosin	2020
[Therapeutic effect of tadalafil on lower urinary tract symptoms with erectile dysfunction]. Zhonghua nan ke xue = National journal of andrology, 2019, Volume: 25, Issue:6 Topics: Carbolines; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome	2019
Efficacy and safety of tadalafil vs tamsulosin in lower urinary tract symptoms (LUTS) as a result of benign prostate hyperplasia (BPH)-open label randomised controlled study. International journal of clinical practice, 2020, Volume: 74, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2020
Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO. World journal of urology, 2021, Volume: 39, Issue:6 Topics: Acetanilides; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Solifenacin Succinate; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive	2021
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study. Urology, 2021, Volume: 147 Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive	2021
An Exploratory Analysis of Tamsulosin for Overactive Bladder (OAB) in Men With Varying Voiding Symptom Burden. Urology, 2021, Volume: 153 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cost of Illness; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Symptom Assessment; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive	2021
Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study. Urologia internationalis, 2021, Volume: 105, Issue:9-10 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Dutasteride; Humans; Imidazoles; Japan; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Quality of Life; Recovery of Function; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents	2021
Efficacy and safety of tamsulosin vs its combination with mirabegron in the management of lower urinary tract non-neurogenic overactive bladder symptoms (OABS) because of Benign Prostatic Enlargement (BPE)-An open label randomised controlled clinical stud International journal of clinical practice, 2021, Volume: 75, Issue:7 Topics: Acetanilides; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive	2021
Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Inflammopharmacology, 2017, Volume: 25, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Fatty Acids, Omega-3; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents	2017
Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study) International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:7 Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Drug Therapy, Combination; Dutasteride; Humans; Imidazoles; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive	2017
Comparison of the Effect of Naftopidil 75 mg and Tamsulosin 0.2 mg on the Bladder Storage Symptom With Benign Prostatic Hyperplasia: Prospective, Multi-institutional Study. Urology, 2018, Volume: 111 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases	2018
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial. The journal of sexual medicine, 2017, Volume: 14, Issue:8 Topics: Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2017
The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia. Current eye research, 2017, Volume: 42, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Choroid; Color Vision; Diagnostic Techniques, Ophthalmological; Humans; Iris; Male; Middle Aged; Night Vision; Organ Size; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Tamsulosin; Tomography, Optical Coherence	2017
[Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines]. Urologiia (Moscow, Russia : 1999), 2017, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Drug Combinations; Dutasteride; Humans; Male; Middle Aged; Practice Guidelines as Topic; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2017
A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU international, 2018, Volume: 121, Issue:4 Topics: Aged; Aged, 80 and over; Dutasteride; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Penile Erection; Placebos; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urological Agents	2018
[Effectiveness of Omnic and Omnic Ocas in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia (multi-center observing program)]. Urologiia (Moscow, Russia : 1999), 2017, Issue:5 Topics: Aged; Delayed-Action Preparations; Humans; Kazakhstan; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2017
Role of silodosin in patients with LUTS/BPE non responding to medical treatment with tamsulosin: a prospective, open-label, pilot study. European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:21 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Pilot Projects; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2017
An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with tre Clinical interventions in aging, 2018, Volume: 13 Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Tolerance; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination; Urological Agents	2018
Efficacy and safety of tamsulosin 0.4 mg single pills for treatment of Asian patients with symptomatic benign prostatic hyperplasia with lower urinary tract symptoms: a randomized, double-blind, phase 3 trial. Current medical research and opinion, 2018, Volume: 34, Issue:10 Topics: Aged; Asian People; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Republic of Korea; Tamsulosin; Treatment Outcome; Urological Agents	2018
[Combination drug therapy in patients with BPH]. Urologiia (Moscow, Russia : 1999), 2018, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Combinations; Dutasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders	2018
[Combination therapy in the management of urinary disorders after transurethral resection of the prostate]. Urologiia (Moscow, Russia : 1999), 2018, Issue:1 Topics: Drug Combinations; Humans; Male; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urination Disorders; Urological Agents	2018
Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial. World journal of urology, 2018, Volume: 36, Issue:10 Topics: Aged; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Safety; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neoplasms; Urological Agents	2018
[The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)]. Urologiia (Moscow, Russia : 1999), 2018, Issue:2 Topics: Aged; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Recovery of Function; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urologic Diseases	2018
Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:8 Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Greece; Humans; Male; Middle Aged; Muscarinic Antagonists; Organ Size; Pilot Projects; Prospective Studies; Prostate; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Tamsulosin; Urinary Bladder, Overactive; Urination	2018
Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial. Urologia, 2018, Volume: 85, Issue:2 Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention	2018
Effect of phenylephrine 1.0%-ketorolac 0.3% injection on tamsulosin-associated intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2018, Volume: 44, Issue:9 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Double-Blind Method; Drug Combinations; Humans; Injections, Intraocular; Intraoperative Complications; Iris Diseases; Ketorolac; Male; Middle Aged; Miosis; Phenylephrine; Prospective Studies; Prostatic Hyperplasia; Tamsulosin	2018
Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:11 Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Asian People; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Severity of Illness Index; Single-Blind Method; Taiwan; Tamsulosin; Treatment Outcome; Urinary Retention	2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study). Lower urinary tract symptoms, 2019, Volume: 11, Issue:3 Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Dutasteride; Humans; Imidazoles; Male; Prostatic Hyperplasia; Severity of Illness Index; Tamsulosin; Urinary Bladder, Overactive; Urological Agents	2019
Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study. World journal of urology, 2019, Volume: 37, Issue:7 Topics: Aged; Cholecalciferol; Drug Therapy, Combination; Humans; Incidence; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Recurrence; Tamsulosin; Treatment Outcome; Urinary Tract Infections; Urological Agents; Vitamins	2019
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:2 Topics: Aged; China; Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Republic of Korea; Severity of Illness Index; Tadalafil; Taiwan; Tamsulosin; Treatment Outcome	2019
The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study. BMC urology, 2018, Dec-13, Volume: 18, Issue:1 Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Placebo Effect; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urological Agents	2018
Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin. Drugs & aging, 2019, Volume: 36, Issue:2 Topics: Adult; Health Behavior; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nonprescription Drugs; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Treatment Outcome; Urological Agents	2019
The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin. Current medical research and opinion, 2013, Volume: 29, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Double-Blind Method; Drug Interactions; Erectile Dysfunction; Healthy Volunteers; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Placebos; Prostatic Hyperplasia; Pyrimidines; Sulfonamides; Tamsulosin; Young Adult	2013
Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Urology, 2013, Volume: 82, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Libido; Male; Middle Aged; Organ Size; Orgasm; Penile Erection; Prostate; Prostatic Hyperplasia; Prostatism; Sexual Behavior; Sexual Dysfunction, Physiological; Single-Blind Method; Statistics, Nonparametric; Sulfonamides; Tamsulosin	2013
Clinical efficacy and safety of imidafenacin as add-on treatment for persistent overactive bladder symptoms despite α-blocker treatment in patients with BPH: the ADDITION study. Urology, 2013, Volume: 82, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Imidazoles; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive	2013
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study. Acta medica Okayama, 2013, Volume: 67, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2013
Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial). Prostate cancer and prostatic diseases, 2013, Volume: 16, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Ketoconazole; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2013
A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth. International urology and nephrology, 2014, Volume: 46, Issue:4 Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Aged; Device Removal; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Recovery of Function; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination	2014
Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study. International urology and nephrology, 2014, Volume: 46, Issue:3 Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive	2014
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results BJU international, 2014, Volume: 113, Issue:4 Topics: 5-alpha Reductase Inhibitors; Acute Disease; Administration, Oral; Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination	2014
A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. The journal of sexual medicine, 2014, Volume: 11, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Retention	2014
Prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin. Ophthalmology, 2014, Volume: 121, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Sectional Studies; Double-Blind Method; Humans; Intraoperative Complications; Iris Diseases; Lens Implantation, Intraocular; Male; Phacoemulsification; Prolapse; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Risk Factors; Severity of Illness Index; Sulfonamides; Tamsulosin; Video Recording	2014
Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia? Vojnosanitetski pregled, 2013, Volume: 70, Issue:12 Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Phytotherapy; Pilot Projects; Plant Extracts; Prospective Studies; Prostatic Hyperplasia; Prostatism; Serenoa; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents	2013
Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study. BJU international, 2014, Volume: 114, Issue:4 Topics: Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urological Agents	2014
Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia. Scandinavian journal of urology, 2014, Volume: 48, Issue:4 Topics: Aged; Aged, 80 and over; Catheters, Indwelling; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Muscle Tonus; Muscle, Smooth; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder; Urinary Catheterization; Urinary Retention; Urological Agents	2014
Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: a randomized placebo controlled trial. International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Asian People; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination	2014
[Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder]. Zhonghua nan ke xue = National journal of andrology, 2014, Volume: 20, Issue:3 Topics: Aged; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive	2014
Nocturia improvement in the combination of Avodart(®) and tamsulosin (CombAT) study. World journal of urology, 2014, Volume: 32, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Combinations; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2014
Is the double dose alpha-blocker treatment superior than the single dose in the management of patients suffering from acute urinary retention caused by benign prostatic hyperplasia? Urology journal, 2014, Jul-08, Volume: 11, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Dizziness; Drug Therapy, Combination; Headache; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Retention	2014
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension. European urology, 2015, Volume: 67, Issue:2 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Double-Blind Method; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents	2015
The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia. World journal of urology, 2015, Volume: 33, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Antidiuretic Agents; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urine; Urological Agents	2015
Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). The Prostate, 2014, Volume: 74, Issue:15 Topics: Aged; Aged, 80 and over; Antioxidants; Carotenoids; Double-Blind Method; Drug Therapy, Combination; Humans; Italy; Lower Urinary Tract Symptoms; Lycopene; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Selenium; Serenoa; Sulfonamides; Tamsulosin; Treatment Outcome; Urodynamics; Urological Agents	2014
A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction. The Journal of urology, 2015, Volume: 193, Issue:3 Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Thiazoles; Urinary Bladder, Overactive	2015
Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2014, Volume: 17, Issue:8 Topics: Aged; Aged, 80 and over; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Psychometrics; Quinuclidines; Reproducibility of Results; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tetrahydroisoquinolines; Urological Agents	2014
Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart(®) ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management o BJU international, 2015, Volume: 116, Issue:3 Topics: Aged; Azasteroids; Dutasteride; Humans; Life Style; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents; Watchful Waiting	2015
Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study. Urologia internationalis, 2015, Volume: 94, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Asian People; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Republic of Korea; Serenoa; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Bladder; Urodynamics; Urological Agents	2015
Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study. BJU international, 2016, Volume: 117, Issue:1 Topics: Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urological Agents	2016
Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia. American journal of men's health, 2016, Volume: 10, Issue:2 Topics: Benzilates; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urodynamics	2016
Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. The Prostate, 2015, Volume: 75, Issue:16 Topics: Aged; Androgen Antagonists; Biomarkers; Double-Blind Method; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Serenoa; Sulfonamides; Tamsulosin; Treatment Outcome	2015
[Combination therapy of Xipayimaizipizi Capsules and Tamsulosin for benign prostatic hyperplasia]. Zhonghua nan ke xue = National journal of andrology, 2015, Volume: 21, Issue:11 Topics: Aged; Capsules; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2015
Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Lower urinary tract symptoms, 2016, Volume: 8, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Over Studies; Drug Therapy, Combination; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome	2016
[Cost and effectiveness analysis of treatments for benign prostatic hyperplasia]. Zhonghua yi xue za zhi, 2016, Jan-26, Volume: 96, Issue:4 Topics: Cost-Benefit Analysis; Humans; Male; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2016
Initial Use of High-Dose Anticholinergics Combined with Alpha-Blockers for Male Lower Urinary Tract Symptoms with Overactive Bladder: A Prospective, Randomized Preliminary Study. Lower urinary tract symptoms, 2017, Volume: 9, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents	2017
A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia. Medical science monitor : international medical journal of experimental and clinical research, 2016, Jun-04, Volume: 22 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2016
[A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin]. Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:7 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive	2016
Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial. Urology journal, 2016, 12-08, Volume: 13, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tadalafil; Tamsulosin	2016
Efficacy and Safety of Medium-to-long-term Use of Tolterodine Extended Release with or without Tamsulosin in Patients with Benign Prostate Hyperplasia and Larger Prostate Size: A Double-blind, Placebo-controlled, Randomized Clinical Trial. Chinese medical journal, 2016, 12-20, Volume: 129, Issue:24 Topics: Adrenergic alpha-Antagonists; Aged; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome	2016
The effective tool for self-assessment of adherence to treatment in patients with benign prostatic obstruction and overactive bladder symptoms. The aging male : the official journal of the International Society for the Study of the Aging Male, 2017, Volume: 20, Issue:1 Topics: Aged; Benzilates; Diagnostic Self Evaluation; Drug Therapy, Combination; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Self-Assessment; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urinary Bladder, Overactive	2017
[Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?] Urologiia (Moscow, Russia : 1999), 2016, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Age Factors; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone; Transurethral Resection of Prostate; Treatment Outcome	2016
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score. BJU international, 2008, Volume: 102, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Prostatism; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive	2008
Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study. The journal of sexual medicine, 2008, Volume: 5, Issue:9 Topics: Aged; Carbolines; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Retention	2008
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. The Journal of urology, 2008, Volume: 180, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge	2008
Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH. Prostate cancer and prostatic diseases, 2009, Volume: 12, Issue:2 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Azasteroids; Double-Blind Method; Dutasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2009
Effect of naftopidil on nocturia after failure of tamsulosin. Urology, 2008, Volume: 72, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Quality of Life; Retreatment; Sulfonamides; Tamsulosin; Treatment Failure	2008
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB. Urology, 2008, Volume: 72, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders	2008
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT stu European urology, 2009, Volume: 55, Issue:2 Topics: Adrenergic alpha-Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Male; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2009
[Economic evaluation of medical treatment of benign prostatic hyperplasia (BPH) in the specialised care setting in Spain. Application to the cost-effectiveness of two drugs frequently used in its treatment]. Actas urologicas espanolas, 2008, Volume: 32, Issue:9 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cost-Benefit Analysis; Double-Blind Method; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Serenoa; Spain; Sulfonamides; Tamsulosin	2008
Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study. International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:12 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2008
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial. BJU international, 2009, Volume: 103, Issue:7 Topics: Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Prostatism; Quality of Life; Severity of Illness Index; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urodynamics	2009
Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urological research, 2009, Volume: 37, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Stents; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Ureteral Calculi	2009
[One-week effects of Tamsulosin on benign prostatic hyperplasia assessed with a daily symptom score]. Hinyokika kiyo. Acta urologica Japonica, 2009, Volume: 55, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Drug Combinations; Ethamsylate; Humans; Male; Medical Records; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Retention	2009
Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study. Urologia internationalis, 2009, Volume: 83, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2009
Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2009, Volume: 16, Issue:9 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Asian People; Azasteroids; Double-Blind Method; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasound, High-Intensity Focused, Transrectal; Urodynamics	2009
[Combination of tolterodine and tamsulosin for benign prostatic hyperplasia]. Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:7 Topics: Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome	2009
Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia. BJU international, 2010, Volume: 105, Issue:7 Topics: Adrenergic alpha-Antagonists; Aged; Azasteroids; Body Mass Index; Cholestenone 5 alpha-Reductase; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone; Treatment Outcome	2010
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. European urology, 2010, Volume: 57, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Azasteroids; Brazil; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; North America; Proportional Hazards Models; Prostatic Hyperplasia; Risk Assessment; Risk Factors; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Retention; Urologic Surgical Procedures, Male	2010
The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study. Prostate cancer and prostatic diseases, 2009, Volume: 12, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urination	2009
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study. International journal of clinical practice, 2010, Volume: 64, Issue:8 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Prostatism; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2010
Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2010, Volume: 17, Issue:10 Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Humans; Indoles; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Tract; Urination Disorders	2010
[A randomized controlled study comparing clinical effects of naftopidil and tamsulosin on benign prostatic hyperplasia]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:9 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urination	2010
Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial. European urology, 2011, Volume: 59, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Biopsy; Drug Therapy, Combination; Dutasteride; Humans; Incidence; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Risk Factors; Sulfonamides; Tamsulosin; Urination Disorders	2011
Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. European urology, 2011, Volume: 59, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Europe; Humans; Indoles; Male; Middle Aged; Nocturia; Placebo Effect; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination; Urination Disorders	2011
[Combination of tamsulosin and tolterodine alleviates refractory lower urinary tract symptoms in male patients]. Zhonghua nan ke xue = National journal of andrology, 2010, Volume: 16, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome	2010
Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Ejaculation; Erectile Dysfunction; Humans; Indoles; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination; Urination Disorders	2011
Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulo BJU international, 2011, Volume: 107, Issue:6 Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Drug Therapy, Combination; Dutasteride; Epidemiologic Methods; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2011
Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Nocturia; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2011
The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) s BJU international, 2011, Volume: 107, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Drug Therapy, Combination; Dutasteride; Epidemiologic Methods; Humans; Male; Middle Aged; Organ Size; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Treatment Outcome	2011
Long-term efficacy and safety of tamsulosin hydrochloride for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: data from China. Chinese medical journal, 2011, Volume: 124, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; China; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin	2011
Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia. International urology and nephrology, 2011, Volume: 43, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Over Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Quality of Life; Quinazolines; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Treatment Outcome	2011
The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study. Prostate cancer and prostatic diseases, 2011, Volume: 14, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Disease Progression; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2011
Long-term outcome of tamsulosin for patients with lower urinary tract symptoms according to the treatment response defined by lower urinary tract symptom outcomes score. International journal of clinical practice, 2011, Volume: 65, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Male; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Treatment Outcome; Urodynamics	2011
Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). BJU international, 2011, Volume: 108, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urodynamics	2011
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial. International journal of radiation oncology, biology, physics, 2011, Nov-15, Volume: 81, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Brachytherapy; Humans; Indoles; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Sulfonamides; Tamsulosin	2011
A randomized crossover study comparing patient preference for tamsulosin and silodosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia. The Journal of international medical research, 2011, Volume: 39, Issue:1 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Humans; Indoles; Japan; Male; Middle Aged; Patient Preference; Prostatic Hyperplasia; Research Design; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urination	2011
Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study. Urology, 2011, Volume: 78, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2011
Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? British journal of clinical pharmacology, 2011, Volume: 72, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Blood Proteins; Humans; Male; Middle Aged; Orosomucoid; Prostate; Prostatic Hyperplasia; Protein Binding; Sulfonamides; Tamsulosin	2011
Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study. International journal of clinical practice, 2011, Volume: 65, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2011
Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart. Neurourology and urodynamics, 2012, Volume: 31, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Circadian Rhythm; Humans; Longitudinal Studies; Male; Middle Aged; Nocturia; Polyuria; Prevalence; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urine; Urodynamics	2012
Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial. Clinical therapeutics, 2011, Volume: 33, Issue:12 Topics: Administration, Oral; Aged; Analysis of Variance; Capsules; Double-Blind Method; Humans; Male; Medication Adherence; Medicine, Ayurvedic; Middle Aged; Murraya; Organ Size; Plant Extracts; Plants, Medicinal; Prostate; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Time Factors; Treatment Outcome; Tribulus; Ultrasonography; Urodynamics	2011
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. European urology, 2012, Volume: 61, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Carbolines; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Vasodilator Agents	2012
Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. The Journal of urology, 2012, Volume: 187, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Double-Blind Method; Dutasteride; Humans; Male; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin	2012
A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. The journal of sexual medicine, 2012, Volume: 9, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Triazines; Vardenafil Dihydrochloride	2012
Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study. International journal of urology : official journal of the Japanese Urological Association, 2012, Volume: 19, Issue:11 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Azasteroids; Double-Blind Method; Dutasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; White People	2012
Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Nepal Medical College journal : NMCJ, 2011, Volume: 13, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sensitivity and Specificity; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urinary Retention	2011
Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men. International journal of urology : official journal of the Japanese Urological Association, 2013, Volume: 20, Issue:2 Topics: Administration, Oral; Aged; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Selection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostatic Hyperplasia; Reference Values; Risk Assessment; Severity of Illness Index; Sulfonamides; Tadalafil; Tamsulosin; Treatment Outcome; Urination; Urodynamics	2013
α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study. International journal of urology : official journal of the Japanese Urological Association, 2013, Volume: 20, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Disease Progression; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Dropouts; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders	2013
Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial. International urology and nephrology, 2013, Volume: 45, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder, Overactive; Urination; Urodynamics	2013
Treatment satisfaction with low-dose tamsulosin for symptomatic benign prostatic hyperplasia: results from a multicentre cross-sectional survey. International journal of clinical practice, 2012, Volume: 66, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cross-Sectional Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination	2012
Lower urinary tract symptoms associated with benign prostatic hyperplasia: combined treatment with fesoterodine fumarate extended-release and tamsulosin--a prospective study. Urologia internationalis, 2013, Volume: 90, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Tract	2013
The effect of first dose of tamsulosin on flow rate and its predictive ability on the improvement of LUTS in men with BPH in the mid-term. International urology and nephrology, 2013, Volume: 45, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Humans; Male; Middle Aged; Predictive Value of Tests; Prostatic Hyperplasia; Prostatism; Quality of Life; Rheology; Sulfonamides; Tamsulosin; Time Factors; Ultrasonography; Urodynamics	2013
Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin The journal of sexual medicine, 2013, Volume: 10, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Analysis of Variance; Carbolines; Double-Blind Method; Drug Administration Schedule; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tadalafil; Tamsulosin	2013
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2002, Volume: 12, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Prostate-Specific Antigen; Prostatic Hyperplasia; Sensitivity and Specificity; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin	2002
[Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2002, Volume: 12, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Androgen Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Placebo Effect; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin	2002
A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia. BJU international, 2003, Volume: 91, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2003
Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. The Journal of urology, 2003, Volume: 169, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urodynamics	2003
Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. The Journal of urology, 2003, Volume: 170, Issue:2 Pt 1 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders; Urodynamics	2003
[Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention]. Zhonghua nan ke xue = National journal of andrology, 2003, Volume: 9, Issue:7 Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urinary Retention	2003
Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study. International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:11 Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Dizziness; Headache; Humans; Hypotension, Orthostatic; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders	2003
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Prostate cancer and prostatic diseases, 2003, Volume: 6, Issue:4 Topics: Aged; Aged, 80 and over; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sexual Behavior; Sulfonamides; Tamsulosin; Urination Disorders	2003
Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis. International journal of clinical practice, 2004, Volume: 58, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2004
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. European urology, 2004, Volume: 45, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Androgen Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin	2004
Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5 Topics: Clinical Trials as Topic; Doxazosin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2004
Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report. Archivos espanoles de urologia, 2004, Volume: 57, Issue:4 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors	2004
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2004, Volume: 14, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Androgen Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin	2004
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2004, Volume: 11, Issue:10 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors	2004
Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Urology, 2004, Volume: 64, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Electrocardiography; Heart Rate; Humans; Hypotension, Orthostatic; Imidazoles; Male; Middle Aged; Piperazines; Posture; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Triazines; Vardenafil Dihydrochloride	2004
Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU international, 2005, Volume: 95, Issue:3 Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Retention	2005
Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia. BJU international, 2005, Volume: 95, Issue:7 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders	2005
Tamsulosin in the treatment of LUTS/BPH: an Italian multicentre trial. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2005, Volume: 77, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Italy; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2005
Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial. BJU international, 2005, Volume: 96, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Urodynamics	2005
Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU international, 2006, Volume: 97, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2006
A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil. International journal of clinical practice, 2006, Volume: 60, Issue:10 Topics: Adrenergic alpha-Antagonists; Aged; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2006
Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU international, 2006, Volume: 98, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Double-Blind Method; Humans; Indoles; Japan; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin; Treatment Outcome	2006
[Sexual function of men with symptomatic benign prostatic hyperplasia and effect of Tamsulosin]. Zhonghua nan ke xue = National journal of andrology, 2006, Volume: 12, Issue:8 Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome	2006
Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. Yonsei medical journal, 2006, Oct-31, Volume: 47, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Botulinum Toxins, Type A; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Neuromuscular Agents; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2006
Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:11 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Doxazosin; Heart Rate; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Diseases; Urinary Bladder Neck Obstruction; Urodynamics	2006
The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement. The Journal of urology, 2006, Volume: 176, Issue:6 Pt 1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Aged; Algorithms; Blood Pressure; Cardiography, Impedance; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Heart Rate; Humans; Male; Middle Aged; Piperazines; Prostatic Hyperplasia; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tamsulosin; Tilt-Table Test; Vascular Resistance	2006
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA, 2006, Nov-15, Volume: 296, Issue:19 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge	2006
The effectiveness of a treatment protocol for male lower urinary tract symptoms in general practice: a practical randomised controlled trial. The British journal of general practice : the journal of the Royal College of General Practitioners, 2006, Volume: 56, Issue:533 Topics: Aged; Clinical Protocols; Cohort Studies; Enzyme Inhibitors; Family Practice; Finasteride; Humans; Male; Middle Aged; Netherlands; Practice Guidelines as Topic; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urinary Tract Infections	2006
A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia. International urology and nephrology, 2007, Volume: 39, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Drug Therapy, Combination; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Prostatic Hyperplasia; Serenoa; Sulfonamides; Tamsulosin; Treatment Outcome	2007
Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients. International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; China; Delayed-Action Preparations; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2007
The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study. Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Single-Blind Method; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Visual Acuity	2007
Crossover comparison study on the therapeutic effects of tamsulosin hydrochloride and naftopidil in lower urinary tract symptoms associated with benign prostatic hyperplasia. Drugs of today (Barcelona, Spain : 1998), 2007, Volume: 43 Suppl A Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders	2007
Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score. Drugs of today (Barcelona, Spain : 1998), 2007, Volume: 43 Suppl B Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Humans; Male; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Sickness Impact Profile; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Tract	2007
Comparison of efficacy between Tamsulosin and Finasteride on symptomatic Benign Prostatic Hyperplasia. Mymensingh medical journal : MMJ, 2007, Volume: 16, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2007
Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design. Contemporary clinical trials, 2007, Volume: 28, Issue:6 Topics: Aged; Antineoplastic Agents; Azasteroids; Clinical Trials as Topic; Combined Modality Therapy; Dutasteride; Enzyme Inhibitors; Humans; Male; Middle Aged; Prostatic Hyperplasia; Research Design; Sulfonamides; Tamsulosin	2007
[Comparison of different drugs on the treatment of benign prostate hyperplasia]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, Jul-15, Volume: 45, Issue:14 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome	2007
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. The Journal of urology, 2008, Volume: 179, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urination Disorders	2008
Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia. The Journal of urology, 2008, Volume: 179, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Biopsy; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sulfonamides; Tamsulosin; Treatment Outcome	2008
Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group. British journal of urology, 1995, Volume: 76, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Delayed-Action Preparations; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction	1995
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tam European urology, 1996, Volume: 29, Issue:2 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Blood Pressure; Double-Blind Method; Humans; Life Style; Longitudinal Studies; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination	1996
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. European urology, 1996, Volume: 29, Issue:2 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Europe; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Pulse; Sulfonamides; Tamsulosin; Urination	1996
[Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1996, Volume: 87, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Combined Modality Therapy; Humans; Male; Middle Aged; Muscle, Smooth; Prostate; Prostatectomy; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1996
[Urodynamic evaluation of alpha-1 blocker tamsulosin on benign prostatic hyperplasia using pressure-flow study]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1996, Volume: 87, Issue:8 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urodynamics	1996
Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia. The Kobe University YM617 Study Group. Scandinavian journal of urology and nephrology, 1996, Volume: 30, Issue:5 Topics: Adrenergic alpha-Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Progesterone Congeners; Prostatectomy; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin; Urodynamics	1996
Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy. British journal of urology, 1997, Volume: 80, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Forecasting; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	1997
Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group. British journal of urology, 1997, Volume: 80, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urination	1997
A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia). British journal of urology, 1997, Volume: 80, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Pressure; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urination; Urodynamics	1997
Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. British journal of urology, 1997, Volume: 80, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination	1997
[Clinical evaluation of tamsulosin hydrochloride on bladder outlet obstruction associated with benign prostatic hyperplasia: effect on urethral pressure profile and cystometrogram]. Hinyokika kiyo. Acta urologica Japonica, 1997, Volume: 43, Issue:11 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Manometry; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics	1997
Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group. Urology, 1998, Volume: 51, Issue:6 Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group. Urology, 1998, Volume: 51, Issue:6 Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Remission Induction; Sulfonamides; Tamsulosin; Time Factors	1998
A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. European urology, 1998, Volume: 33, Issue:5 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Heart Rate; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Retention; Urodynamics; Vertigo	1998
A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group. The Journal of urology, 1998, Volume: 160, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia? Canadian family physician Medecin de famille canadien, 1998, Volume: 44 Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Double-Blind Method; Humans; Hypotension; Male; Middle Aged; Placebos; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1998
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. Urology, 1999, Volume: 53, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Chemotherapy, Adjuvant; Diathermy; Humans; Male; Microwaves; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urodynamics	1999
Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. European urology, 1999, Volume: 36, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Incidence; Libido; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Obstruction	1999
Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group. Journal of medicine, 1998, Volume: 29, Issue:5-6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Dose-Response Relationship, Drug; Humans; Hypotension; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction	1998
Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: analysis of a European, multinational, multicenter, open-label study. European Tamsulosin Study Group. European urology, 1999, Volume: 36, Issue:6 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Heart Rate; Humans; Longitudinal Studies; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination	1999
Prediction of alpha-blocker response in men with benign prostatic hyperplasia by magnetic resonance imaging. Urology, 1999, Volume: 54, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Magnetic Resonance Imaging; Male; Predictive Value of Tests; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urodynamics	1999
The short-term effects of tamsulosin in Japanese men with benign prostatic hyperplasia. Nihon Ika Daigaku zasshi, 1999, Volume: 66, Issue:6 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	1999
A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients. BJU international, 2000, Volume: 85, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin	2000
Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2000, Volume: 7, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urodynamics	2000
[A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS]. Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:11 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Drug Therapy, Combination; Humans; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urodynamics	2000
[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy]. Hinyokika kiyo. Acta urologica Japonica, 2001, Volume: 47, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2001
[Treatment of benign prostatic hyperplasia with tamsulosin]. Khirurgiia, 1998, Volume: 53, Issue:6 Topics: Aged; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urinary Retention	1998
Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia. Urology, 2001, Volume: 57, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2001
A 6-month large-scale study into the safety of tamsulosin. British journal of clinical pharmacology, 2001, Volume: 51, Issue:6 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Interactions; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Time Factors; Verapamil	2001
Our experience with the treatment of benign prostatic hyperplasia (BPH) with tamsulosin. Bratislavske lekarske listy, 2001, Volume: 102, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2001
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia]. Hinyokika kiyo. Acta urologica Japonica, 2002, Volume: 48, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2002
Clinical characteristics of alpha-blocker responders in men with benign prostatic hyperplasia. Urologia internationalis, 2002, Volume: 68, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2002
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. European urology, 2002, Volume: 41, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Double-Blind Method; Humans; Male; Middle Aged; Plant Extracts; Prostate-Specific Antigen; Prostatic Hyperplasia; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urodynamics	2002
[Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study]. Hinyokika kiyo. Acta urologica Japonica, 2002, Volume: 48, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Secale; Sulfonamides; Tamsulosin; Urination Disorders	2002
[Clinical efficacy and safety of long-term administration of YM617 for urinary obstruction of the lower urinary tract]. Hinyokika kiyo. Acta urologica Japonica, 1991, Volume: 37, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Evaluation; Female; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethral Obstruction; Urinary Bladder Neck Obstruction	1991

Other Studies

290 other study(ies) available for tamsulosin and Adenoma, Prostatic

Article	Year
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists. Journal of medicinal chemistry, 1997, Aug-15, Volume: 40, Issue:17 Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amides; Animals; Binding, Competitive; Humans; Male; Middle Aged; Models, Chemical; Muscle, Smooth; Piperazines; Prazosin; Propylamines; Prostatic Hyperplasia; Rabbits; Rats; Structure-Activity Relationship; Urinary Bladder	1997
Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist Journal of medicinal chemistry, 1997, Sep-26, Volume: 40, Issue:20 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Humans; Indoles; Isoindoles; Male; Models, Chemical; Prazosin; Prostatic Hyperplasia; Pyrimidinones; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH). Journal of medicinal chemistry, 2000, Apr-20, Volume: 43, Issue:8 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cell Line; Dogs; Heterocyclic Compounds, 3-Ring; Indoles; Male; Pressure; Prostatic Hyperplasia; Radioligand Assay; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Urethra	2000
Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists. Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Drug Design; Humans; Male; Muscle Contraction; Phthalimides; Piperazines; Prostatic Hyperplasia; Radioligand Assay; Rats; Rats, Long-Evans; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Vasoconstriction	2000
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 2000, Jul-13, Volume: 43, Issue:14 Topics: Adrenergic alpha-Antagonists; Animals; Biological Availability; Caco-2 Cells; Crystallography, X-Ray; Dogs; Humans; Male; Prostatic Hyperplasia; Pyrimidinones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship	2000
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens	2001
(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS). Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Binding Sites; Cloning, Molecular; Humans; Ligands; Male; Models, Chemical; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Structure-Activity Relationship; Sulfonamides; Urologic Diseases	2007
(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorganic & medicinal chemistry letters, 2007, Jul-15, Volume: 17, Issue:14 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Humans; Male; Prostatic Hyperplasia; Structure-Activity Relationship; Sulfonamides	2007
(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorganic & medicinal chemistry letters, 2008, Jan-15, Volume: 18, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Male; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Urea	2008
The one-pot synthesis of butyl-1H-indol-3-alkylcarboxylic acid derivatives in ionic liquid as potent dual-acting agent for management of BPH. European journal of medicinal chemistry, 2020, Nov-01, Volume: 205 Topics: Androgen Receptor Antagonists; Butyric Acid; Carboxylic Acids; Chemistry Techniques, Synthetic; Humans; Ionic Liquids; Male; Prostatic Hyperplasia; Receptors, Androgen	2020
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients. Scientific reports, 2021, 09-29, Volume: 11, Issue:1 Topics: Female; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Quality of Life; Serenoa; Tamsulosin; Treatment Outcome	2021
Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database. BMC urology, 2021, Dec-21, Volume: 21, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Databases, Factual; Drug Therapy, Combination; Dutasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Republic of Korea; Retrospective Studies; Tamsulosin	2021
Assay of new combination of tamsulosin and tadalafil using synchronous spectrofluorimetric method coupled with mathematical tools. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022, Apr-15, Volume: 271 Topics: Drug Therapy, Combination; Humans; Prostatic Hyperplasia; Spectrometry, Fluorescence; Tadalafil; Tamsulosin	2022
Drug Prescription Patterns During Initial Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Study Based on Health Insurance Review and Assessment Database. Journal of Korean medical science, 2022, Mar-28, Volume: 37, Issue:12 Topics: Adult; Drug Prescriptions; Humans; Insurance, Health; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin	2022
Green & Sensitive pH-dependent Spectrofluorimetric Assay of Tamsulosin Hydrochloride and Tadalafil in their New Combined Formulation for Benign Prostatic Hyperplasia: Application to Spiked Human Plasma. Journal of fluorescence, 2022, Volume: 32, Issue:4 Topics: Humans; Hydrogen-Ion Concentration; Male; Prostatic Hyperplasia; Spectrometry, Fluorescence; Tadalafil; Tamsulosin	2022
Development and optimization of a tamsulosin nanostructured lipid carrier loaded with saw palmetto oil and pumpkin seed oil for treatment of benign prostatic hyperplasia. Drug delivery, 2022, Volume: 29, Issue:1 Topics: Cucurbita; Drug Carriers; Excipients; Humans; Lipids; Male; Nanostructures; Particle Size; Plant Extracts; Plant Oils; Prostatic Hyperplasia; Serenoa; Tamsulosin	2022
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression. European urology focus, 2023, Volume: 9, Issue:1 Topics: Azasteroids; Disease Progression; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2023
Use of Glycolysis-Enhancing Drugs and Risk of Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:11 Topics: 5-alpha Reductase Inhibitors; Animals; Glycolysis; Humans; Male; Parkinson Disease; Prostatic Hyperplasia; Tamsulosin	2022
Treatment of benign prostatic hyperplasia and abnormal ejaculation: live imaging reveals tamsulosin - but not tadalafil - induced dysfunction of prostate, seminal vesicles and epididymis. Reproduction (Cambridge, England), 2022, 12-01, Volume: 164, Issue:6 Topics: Ejaculation; Epididymis; Humans; Male; Norepinephrine; Prostate; Prostatic Hyperplasia; Seminal Vesicles; Sulfonamides; Tadalafil; Tamsulosin	2022
[The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia]. Urologiia (Moscow, Russia : 1999), 2022, Issue:6 Topics: Erectile Dysfunction; Humans; Hyperplasia; Male; Prostate; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2022
[Molecular genetic predictors of the efficacy and safety of tamsulosin therapy]. Urologiia (Moscow, Russia : 1999), 2022, Issue:6 Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Molecular Biology; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2022
The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus. Medical archives (Sarajevo, Bosnia and Herzegovina), 2023, Volume: 77, Issue:1 Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Drug Therapy, Combination; Dutasteride; Humans; Male; Muscle, Smooth; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Sulfonamides; Tamsulosin	2023
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan. International journal of clinical pharmacy, 2023, Volume: 45, Issue:5 Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cholinergic Antagonists; Delirium; Humans; Japan; Male; Pharmacovigilance; Prostatic Hyperplasia; Tamsulosin	2023
Characteristics of men with untreated LUTS interested in over-the-counter tamsulosin. The Canadian journal of urology, 2019, Volume: 26, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Nonprescription Drugs; Patient Satisfaction; Pilot Projects; Prospective Studies; Prostatic Hyperplasia; Risk Assessment; Self-Management; Tamsulosin; Treatment Outcome; United States; Urinary Retention	2019
A first case of fixed drug eruption due to Tamsulosin. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:5 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Biopsy; Drug Eruptions; Humans; Leg; Male; Middle Aged; Prostatic Hyperplasia; Skin; Tamsulosin	2020
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial. European urology focus, 2021, Volume: 7, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Tadalafil; Tamsulosin; Urological Agents	2021
Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany . International journal of clinical pharmacology and therapeutics, 2020, Volume: 58, Issue:1 Topics: 5-alpha Reductase Inhibitors; Drug Therapy, Combination; Dutasteride; Germany; Humans; Male; Medication Adherence; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tamsulosin	2020
Development of microemulsion of tamsulosin and dutasteride for benign prostatic hyperplasia therapy. Colloids and surfaces. B, Biointerfaces, 2020, Jan-01, Volume: 185 Topics: Animals; Drug Liberation; Dutasteride; Emulsions; Male; Phase Transition; Prostate; Prostatic Hyperplasia; Rats, Wistar; Reproducibility of Results; Tamsulosin	2020
Smart spectrophotometric assessment of tamsulosin hydrochloride and tadalafil in their new pharmaceutical formulation for treatment of benign prostatic hyperplasia and erectile dysfunction. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2020, Feb-15, Volume: 227 Topics: Adrenergic alpha-1 Receptor Antagonists; Capsules; Drug Combinations; Drug Compounding; Erectile Dysfunction; Humans; Limit of Detection; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Spectrophotometry; Tadalafil; Tamsulosin	2020
A Prospective, Open-Label Comparison of Tamsulosin plus Serenoa repens and Bovine Colostrum versus Tamsulosin Alone in the Treatment of Benign Prostatic Hyperplasia. Urologia internationalis, 2020, Volume: 104, Issue:5-6 Topics: Aged; Animals; Cattle; Colostrum; Drug Combinations; Humans; Male; Phytotherapy; Plant Extracts; Prospective Studies; Prostatic Hyperplasia; Serenoa; Tamsulosin	2020
Evaluation of syncope association with α Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin	2019
Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction. Investigative and clinical urology, 2020, Volume: 61, Issue:1 Topics: Age Factors; Aged; Drug Combinations; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tadalafil; Tamsulosin; Treatment Failure; Urological Agents	2020
To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: A protocol for systematic review and meta analysis. Medicine, 2020, Volume: 99, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Bayes Theorem; Drug Therapy, Combination; Humans; Male; Meta-Analysis as Topic; Network Meta-Analysis; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Research Design; Sildenafil Citrate; Systematic Review as Topic; Tadalafil; Tamsulosin; Vardenafil Dihydrochloride	2020
Editorial Comment. The Journal of urology, 2020, Volume: 203, Issue:6 Topics: Acetanilides; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive	2020
The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse. Medicine, 2020, May-29, Volume: 99, Issue:22 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Alzheimer Disease; Cognition; Data Warehousing; Humans; Male; Propensity Score; Prostatic Hyperplasia; Regression Analysis; Retrospective Studies; Tamsulosin; Urological Agents	2020
Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data. BJU international, 2020, Volume: 126 Suppl 1 Topics: Age Factors; Aged; Australia; Cystoscopy; Drug Therapy, Combination; Dutasteride; Health Care Costs; Hospitalization; Humans; Lasers, Solid-State; Longitudinal Studies; Male; Middle Aged; Minimally Invasive Surgical Procedures; Procedures and Techniques Utilization; Prostatectomy; Prostatic Hyperplasia; Radiofrequency Ablation; Tamsulosin; Transurethral Resection of Prostate; Urological Agents	2020
Morphological Changes of Meibomian Glands in Men With Benign Prostate Hyperplasia. Cornea, 2021, Volume: 40, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Fluorescent Dyes; Fluorophotometry; Humans; Male; Meibomian Gland Dysfunction; Meibomian Glands; Prostatic Hyperplasia; Staining and Labeling; Surveys and Questionnaires; Tamsulosin; Tears	2021
Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications. Urology, 2021, Volume: 148 Topics: Costs and Cost Analysis; Drugs, Generic; Finasteride; Humans; Male; Mandelic Acids; Pennsylvania; Prostatic Hyperplasia; Tamsulosin	2021
Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2020, Oct-01, Volume: 92, Issue:3 Topics: Aged; Combined Modality Therapy; Complementary Therapies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Tamsulosin; Treatment Outcome; Urological Agents	2020
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome. Minerva urology and nephrology, 2021, Volume: 73, Issue:6 Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin	2021
Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression. World journal of urology, 2021, Volume: 39, Issue:7 Topics: 5-alpha Reductase Inhibitors; Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Disease Progression; Drug Combinations; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Symptom Assessment; Tamsulosin; Time Factors; Urinary Retention	2021
[Patient Background Factors Affecting Prescription Drugs for Male Lower Urinary Tract Symptoms: The Multicenter Study of Miyazaki Urological-Network Group]. Hinyokika kiyo. Acta urologica Japonica, 2020, Volume: 66, Issue:12 Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Prescription Drugs; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2020
Perioperative Medical Optimization of Symptomatic Benign Prostatic Hyperplasia Is an Economically Justified Infection Prevention Strategy in Total Joint Arthroplasty. The Journal of arthroplasty, 2021, Volume: 36, Issue:7 Topics: Arthroplasty, Replacement, Hip; Cost-Benefit Analysis; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Transurethral Resection of Prostate	2021
[New approaches to combined therapy of irritative symptoms in patients with benign prostatic hyperplasia]. Urologiia (Moscow, Russia : 1999), 2021, Issue:2 Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2021
Taking the flow out of Flomax. Journal of cataract and refractive surgery, 2021, 06-01, Volume: 47, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Male; Prostatic Hyperplasia; Tamsulosin	2021
Comparison of effects of tamsulosin and silodosin on subfoveal choroidal thickness and pupil size diameters in patients with prostatic hyperplasia. International ophthalmology, 2021, Volume: 41, Issue:12 Topics: Choroid; Humans; Indoles; Male; Prospective Studies; Prostatic Hyperplasia; Pupil; Sulfonamides; Tamsulosin; Tomography, Optical Coherence	2021
Unilateral choroidal detachment following the use of tamsulosin. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2017, Volume: 52, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Choroid; Choroid Diseases; Humans; Male; Microscopy, Acoustic; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tomography, Optical Coherence; Visual Acuity	2017
[Prognostic factors predicting failure of the trial without catheter after tamsulosin in patients with acute urinary retention.] Archivos espanoles de urologia, 2017, Volume: 70, Issue:9 Topics: Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prognosis; Prostatic Hyperplasia; Retrospective Studies; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention	2017
Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage. The aging male : the official journal of the International Society for the Study of the Aging Male, 2018, Volume: 21, Issue:2 Topics: Aged; Case-Control Studies; Cognition; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urological Agents	2018
Priapism: What cause: mental illness, psychotropic medications or poly-substance abuse? The Journal of the Oklahoma State Medical Association, 2016, Volume: 109, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Depressive Disorder, Major; Hepatitis C; Humans; Male; Middle Aged; Phenylephrine; Phosphodiesterase 5 Inhibitors; Priapism; Prostatic Hyperplasia; Selective Serotonin Reuptake Inhibitors; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Sulfonamides; Tamsulosin; Trazodone; Vasoconstrictor Agents	2016
Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:3 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Dementia; Dutasteride; Finasteride; Follow-Up Studies; Humans; Incidence; Male; Medicare; Prostatic Hyperplasia; Retrospective Studies; Risk Factors; Tamsulosin; United States	2018
Beta testing the potential link between the alpha antagonist tamsulosin and dementia. Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:3 Topics: Aged; Dementia; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2018
Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride. Luminescence : the journal of biological and chemical luminescence, 2018, Volume: 33, Issue:4 Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Molecular Structure; Prostatic Hyperplasia; Solifenacin Succinate; Spectrometry, Fluorescence; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2018
Efficacy and safety of low-concentration, bisulphite-containing, intracameral epinephrine and topical atropine treatments for the prevention of intraoperative floppy iris syndrome. Cutaneous and ocular toxicology, 2018, Volume: 37, Issue:3 Topics: Administration, Ophthalmic; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Atropine; Epinephrine; Follow-Up Studies; Humans; Incidence; Injections, Intraocular; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Preoperative Care; Preservatives, Pharmaceutical; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfites; Sulfonamides; Tamsulosin; Treatment Outcome	2018
Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. European journal of clinical pharmacology, 2018, Volume: 74, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Biological Availability; Blood Pressure; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Hemodynamics; Humans; Male; Pharmacogenetics; Polymorphism, Genetic; Prostatic Hyperplasia; Tamsulosin	2018
Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model. Drug design, development and therapy, 2018, Volume: 12 Topics: Administration, Oral; Animals; Benzofurans; Disease Models, Animal; Drug Therapy, Combination; Finasteride; Indoles; Male; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Testosterone	2018
Tamsulosin-induced photosensitivity rash. Singapore medical journal, 2018, Volume: 59, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Betamethasone; Betamethasone Valerate; Clobetasol; Exanthema; Hernia, Inguinal; Humans; Light; Male; Myocardial Ischemia; Ointments; Peptic Ulcer; Photosensitivity Disorders; Prostatic Hyperplasia; Pulmonary Disease, Chronic Obstructive; Steroids; Sulfonamides; Tamsulosin; Tuberculosis, Pulmonary	2018
Re: Tamsulosin and the Risk of Dementia in Older Men with Benign Prostatic Hyperplasia. European urology, 2018, Volume: 74, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Dementia; Humans; Male; Prostatic Hyperplasia; Risk; Tamsulosin	2018
Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Tamsulosin; Treatment Outcome	2018
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis. World journal of urology, 2019, Volume: 37, Issue:5 Topics: Aged; Aged, 80 and over; Costs and Cost Analysis; Drug Therapy, Combination; Finasteride; France; Germany; Humans; Italy; Male; Middle Aged; Prostatic Hyperplasia; Spain; Tamsulosin; Transurethral Resection of Prostate; United Kingdom; Urological Agents	2019
Simultaneous HPLC determination of alfuzosin, tamsulosin and vardenafil in human plasma and pharmaceutical formulations using time programmed fluorescence detection. Annales pharmaceutiques francaises, 2019, Volume: 77, Issue:1 Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Chromatography, High Pressure Liquid; Drug Compounding; Humans; Male; Prostatic Hyperplasia; Quinazolines; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Tamsulosin; Vardenafil Dihydrochloride; Vasodilator Agents	2019
Prescription pattern of alpha-blockers for management of lower urinary tract symptoms/benign prostatic hyperplasia. Scientific reports, 2018, 09-05, Volume: 8, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Cohort Studies; Humans; Male; Middle Aged; Prescription Drug Monitoring Programs; Prostatic Hyperplasia; Republic of Korea; Tamsulosin	2018
[Cost-effectiveness model of a fixed dose combination of solifenacin and tamsulosin for the treatment of LUTS associated with BPH with inadequate response to monotherapy.] Archivos espanoles de urologia, 2018, Volume: 71, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Models, Economic; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome	2018
Editorial Comment to Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:11 Topics: 5-alpha Reductase Inhibitors; Azasteroids; Dutasteride; Humans; Male; Prostatic Hyperplasia; Tamsulosin	2018
Differential prescription behavior in benign prostatic syndrome may explain relationship found between tamsulosin and dementia. Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:11 Topics: Aged; Dementia; Humans; Male; Prescriptions; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2018
Patient-reported Goal Achievement after Treating Male Benign Prostatic Hyperplasia with Alpha-adrenergic Antagonist: A 12-week Prospective Multicenter Study. Urology journal, 2019, 08-18, Volume: 16, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Patient Reported Outcome Measures; Prospective Studies; Prostatic Hyperplasia; Tamsulosin; Time Factors	2019
Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial. The Journal of urology, 2018, Volume: 200, Issue:5 Topics: Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin	2018
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and ta International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:2 Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Tamsulosin	2019
Who are suitable for low-dose tamsulosin monotherapy as initial treatment strategy in male patients with lower urinary tract symptoms? Medicine, 2018, Volume: 97, Issue:44 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Sectional Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; ROC Curve; Sulfonamides; Tamsulosin; Treatment Outcome; Urination	2018
Re: A Prospective Randomised Placebo-controlled Study of the Impact of Dutasteride/Tamsulosin Combination Therapy on Sexual Function Domains in Sexually Active Men with Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH). European urology, 2019, Volume: 75, Issue:2 Topics: Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Tamsulosin	2019
Modified Corneal Incisions for Cataract Surgery in Patients Treated with Tamsulosin: A Prospective Study. Current eye research, 2019, Volume: 44, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Astigmatism; Cornea; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Prospective Studies; Prostatic Hyperplasia; Pupil; Tamsulosin	2019
How to Read a Research Paper: An Exercise in Critical Thinking in the Context of an Epidemiologic Study on Tamsulosin and the Risk of Dementia. The Journal of clinical psychiatry, 2018, 12-11, Volume: 79, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Dementia; Epidemiologic Studies; Humans; Male; Prostatic Hyperplasia; Research Design; Risk Assessment; Tamsulosin; Thinking	2018
Re: Tamsulosin and the Risk of Dementia in Older Men with Benign Prostatic Hyperplasia. The Journal of urology, 2019, Volume: 201, Issue:1 Topics: Dementia; Humans; Male; Prostatic Hyperplasia; Risk; Tamsulosin	2019
Re: Tamsulosin and the Risk of Dementia in Older Men with Benign Prostatic Hyperplasia. The Journal of urology, 2019, Volume: 201, Issue:1 Topics: Dementia; Humans; Male; Prostatic Hyperplasia; Risk; Tamsulosin	2019
Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study. Drugs in R&D, 2019, Volume: 19, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Epidemiological Monitoring; Humans; Indoles; Japan; Male; Middle Aged; Naphthalenes; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Tamsulosin; Treatment Outcome	2019
Evolution in the Risk of Cataract Surgical Complications among Patients Exposed to Tamsulosin: A Population-Based Study. Ophthalmology, 2019, Volume: 126, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cataract Extraction; Databases, Factual; Endophthalmitis; Humans; Intraoperative Complications; Iris Diseases; Lens Subluxation; Male; Posterior Capsular Rupture, Ocular; Prostatic Hyperplasia; Retinal Detachment; Risk Factors; Tamsulosin	2019
Prostatic Artery Embolization via Variant Unilateral Right Prostatic Artery. Journal of vascular and interventional radiology : JVIR, 2019, Volume: 30, Issue:2 Topics: Acrylic Resins; Adrenergic alpha-1 Receptor Antagonists; Angiography; Arteries; Embolization, Therapeutic; Gelatin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome	2019
Vesomni improves the quality of life in men with lower urinary tract symptoms in routine clinical practice in Europe. Neurourology and urodynamics, 2019, Volume: 38, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents	2019
α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database. The Journal of urology, 2019, Volume: 202, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Databases, Factual; Dementia; Humans; Male; National Health Programs; Prostatic Hyperplasia; Republic of Korea; Retrospective Studies; Risk Assessment; Tamsulosin	2019
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study. BMJ (Clinical research ed.), 2019, Apr-10, Volume: 365 Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dutasteride; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin	2019
Re: A Prospective Randomised Placebo-Controlled Study of the Impact of Dutasteride/Tamsulosin Combination Therapy on Sexual Function Domains in Sexually Active Men with Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH). The Journal of urology, 2019, Volume: 201, Issue:5 Topics: Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Tamsulosin	2019
Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Advances in therapy, 2019, Volume: 36, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Electrocardiography, Ambulatory; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Myocardial Ischemia; Prostatic Hyperplasia; Russia; Tamsulosin; Urethral Obstruction; Urological Agents	2019
Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight. Medical archives (Sarajevo, Bosnia and Herzegovina), 2012, Volume: 66, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Bladder	2012
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Atropine; Doxazosin; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; United Kingdom	2013
Corneal endothelial cell changes after cataract surgery in patients on systemic sympathetic α-1a antagonist medication (tamsulosin). Acta ophthalmologica, 2014, Volume: 92, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Axial Length, Eye; Cell Count; Cell Size; Corneal Endothelial Cell Loss; Humans; Intraoperative Complications; Iris Diseases; Lens Implantation, Intraocular; Male; Phacoemulsification; Postoperative Complications; Prospective Studies; Prostatic Hyperplasia; Pupil; Sulfonamides; Tamsulosin; Visual Acuity	2014
Measurement of tamsulosin in human serum by liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013, Jul-01, Volume: 930 Topics: Adolescent; Adult; Chromatography, Liquid; Drug Stability; Humans; Linear Models; Liquid-Liquid Extraction; Male; Middle Aged; Prostatic Hyperplasia; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Tamsulosin; Tandem Mass Spectrometry	2013
Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology. BMJ (Clinical research ed.), 2013, Nov-05, Volume: 347 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Follow-Up Studies; Hospitalization; Humans; Hypotension; Incidence; Male; Middle Aged; Proportional Hazards Models; Prostatic Hyperplasia; Retrospective Studies; Risk Assessment; Sulfonamides; Tamsulosin; United States	2013
Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology, 2013, Volume: 82, Issue:6 Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Cholinergic Antagonists; Disease Management; Drug Therapy, Combination; Dutasteride; Humans; Logistic Models; Lower Urinary Tract Symptoms; Male; Middle Aged; Practice Patterns, Physicians'; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urological Agents	2013
Is transforming growth factor-β signaling activated in human hypertrophied prostate treated by 5-alpha reductase inhibitor? Disease markers, 2013, Volume: 35, Issue:6 Topics: 5-alpha Reductase Inhibitors; Antigens, CD; Cadherins; Combined Modality Therapy; Humans; Hypertrophy; Male; Nitric Oxide Synthase; Prostate; Prostatic Hyperplasia; Signal Transduction; Smad2 Protein; Smad3 Protein; Sulfonamides; Tamsulosin; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Transurethral Resection of Prostate	2013
[Intraoperative floppy iris syndrome--a prospective study]. Oftalmologia (Bucharest, Romania : 1990), 2013, Volume: 57, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Humans; Incidence; Intraoperative Period; Iris Diseases; Male; Phacoemulsification; Prospective Studies; Prostatic Hyperplasia; Pupil; Romania; Sulfonamides; Syndrome; Tamsulosin	2013
Awareness of intraoperative floppy-iris syndrome among primary care physicians. Journal of cataract and refractive surgery, 2014, Volume: 40, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Intraoperative Complications; Iris Diseases; Male; Physicians, Primary Care; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin	2014
Effect of tamsulosin on iris vasculature and morphology. Journal of cataract and refractive surgery, 2014, Volume: 40, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Case-Control Studies; Cataract Extraction; Ciliary Arteries; Fluorescein Angiography; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Muscle, Smooth; Prospective Studies; Prostatic Hyperplasia; Pupil; Sulfonamides; Tamsulosin; Tomography, Optical Coherence	2014
Is there a demonstrated advantage to increase tamsulosin dosage in patients with benign prostatic hyperplasia? Urology, 2014, Volume: 84, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Male; Practice Guidelines as Topic; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2014
Prostatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms. Drug design, development and therapy, 2014, Volume: 8 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Humans; Linear Models; Lower Urinary Tract Symptoms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra; Urination	2014
Measuring the improvement in health-related quality of life using King's health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study. BMC urology, 2014, Aug-06, Volume: 14 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Body Mass Index; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Obesity; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Waist Circumference	2014
Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin. The aging male : the official journal of the International Society for the Study of the Aging Male, 2015, Volume: 18, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzilates; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive	2015
Wound dehiscence as a cataract surgery-associated postoperative complication in patients previously treated with alpha-1 blocker tamsulosin--a population-based study in Taiwan. American journal of ophthalmology, 2014, Volume: 158, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Autoimmune Diseases; Case-Control Studies; Cataract Extraction; Databases, Factual; Diabetes Complications; Female; Humans; Hypertension; Male; Middle Aged; Postoperative Complications; Prostatic Hyperplasia; Retrospective Studies; Sulfonamides; Surgical Wound Dehiscence; Taiwan; Tamsulosin	2014
Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting. BMC urology, 2014, Sep-26, Volume: 14 Topics: Azasteroids; Budgets; Cost-Benefit Analysis; Drug Therapy, Combination; Dutasteride; Greece; Humans; Male; Middle Aged; Office Visits; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urinary Retention; Urological Agents	2014
Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy. International journal of clinical practice, 2014, Volume: 68, Issue:12 Topics: Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder, Overactive	2014
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom	2015
The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis. Journal of general internal medicine, 2015, Volume: 30, Issue:4 Topics: Direct-to-Consumer Advertising; Dutasteride; Humans; Inappropriate Prescribing; Interrupted Time Series Analysis; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; United States; Urological Agents	2015
The Effect of Systemic Tamsulosin Hydrochloride on Choroidal Thickness Measured by Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography. Current eye research, 2015, Volume: 40, Issue:10 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Blood Flow Velocity; Choroid; Ciliary Arteries; Humans; Male; Middle Aged; Ophthalmic Artery; Organ Size; Prospective Studies; Prostatic Hyperplasia; Regional Blood Flow; Retinal Artery; Sulfonamides; Tamsulosin; Tomography, Optical Coherence; Ultrasonography, Doppler, Color	2015
The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity. Turkish journal of medical sciences, 2014, Volume: 44, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Autonomic Nervous System; Blood Glucose; Body Mass Index; Erectile Dysfunction; Humans; Lipids; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Testosterone	2014
Effects of α-blocker therapy on active duty military and military retirees for benign prostatic hypertrophy on diabetic complications. Military medicine, 2015, Volume: 180, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Doxazosin; Humans; Male; Middle Aged; Military Personnel; Prostatic Hyperplasia; Retirement; Retrospective Studies; Sulfonamides; Tamsulosin; United States	2015
Assessment of Tamsulosin 0.2 mg for Symptomatic Bladder Outlet Obstruction Secondary to Benign Prostatic Enlargement: Data from a Korean Multicenter Cross-Sectional Study. Urologia internationalis, 2015, Volume: 95, Issue:1 Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Republic of Korea; Retrospective Studies; Risk Factors; Severity of Illness Index; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urological Agents	2015
Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. BMC urology, 2015, May-09, Volume: 15 Topics: Administration, Oral; Aged; Aged, 80 and over; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urodynamics	2015
Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Hormone molecular biology and clinical investigation, 2015, Volume: 23, Issue:3 Topics: Aged; Cohort Studies; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone; Urological Agents	2015
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence. The Canadian journal of urology, 2015, Volume: 22, Issue:4 Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2015
Combination therapy with tamsulosin and solifenacin for male lower urinary tract symptoms with predominant filling symptoms: a new approach to an old problem. Current medical research and opinion, 2015, Volume: 31, Issue:11 Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin	2015
Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2015, Sep-30, Volume: 87, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Biomarkers, Tumor; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatism; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra	2015
The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study. BMJ (Clinical research ed.), 2015, Oct-26, Volume: 351 Topics: Accidental Falls; Adrenergic alpha-1 Receptor Antagonists; Aged; Canada; Craniocerebral Trauma; Fractures, Bone; Humans; Hypotension; Indoles; Male; Outcome Assessment, Health Care; Prostate; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Risk Factors; Sulfonamides; Tamsulosin	2015
Tamsulosin Treatment Affecting Patient-reported Outcomes in Benign Prostatic Hyperplasia-associated Depressive Symptoms. Urology, 2016, Volume: 87 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Adult; Depression; Dose-Response Relationship, Drug; Endosonography; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Patient Outcome Assessment; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urination	2016
Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016, Volume: 254, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Cornea; Drug Combinations; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2016
Sonographic Parameters Predicting the Outcome of Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treated With Alpha1-Adrenoreceptor Antagonist. Urology, 2016, Volume: 88 Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography	2016
Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2016, Volume: 23, Issue:3 Topics: Animals; Benzofurans; Disease Models, Animal; Electric Stimulation; Estradiol; Humans; Indoles; Male; Pressure; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra	2016
Intravesical Prostatic Protrusion: A Potential Marker of Alpha-blocker Treatment Success in Patients With Benign Prostatic Enlargement. Urology, 2016, Volume: 88 Topics: Abdomen; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Hyperplasia; Rectum; Regional Blood Flow; Remission Induction; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography	2016
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study. International urology and nephrology, 2016, Volume: 48, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Prostatic Hyperplasia; Prostatism; Quality of Life; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin; Watchful Waiting	2016
Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study. World journal of urology, 2017, Volume: 35, Issue:3 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Disease Progression; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Watchful Waiting	2017
A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model. BMC cancer, 2016, 07-07, Volume: 16 Topics: Cost-Benefit Analysis; Drug Combinations; Dutasteride; Health Care Costs; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Nigeria; Prostatic Hyperplasia; Quality-Adjusted Life Years; Socioeconomic Factors; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention	2016
Assessment of Urologists' Knowledge of Intraoperative Floppy Iris Syndrome. Urology, 2016, Volume: 97 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Competence; Fellowships and Scholarships; Female; Finasteride; Health Knowledge, Attitudes, Practice; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Medical Staff, Hospital; Ophthalmology; Patient Education as Topic; Prazosin; Prostatic Hyperplasia; Referral and Consultation; Sulfonamides; Surveys and Questionnaires; Syndrome; Tamsulosin; Urological Agents; Urology; Vision Disorders	2016
Re: Long-Term Safety and Efficacy of Single-Tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-Label Extensio The Journal of urology, 2016, Volume: 196, Issue:2 Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Neptune; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tablets; Tamsulosin; Treatment Outcome	2016
Re: Comparison of Tamsulosin plus Serenoa repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study. The Journal of urology, 2016, Volume: 196, Issue:2 Topics: Humans; Male; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Serenoa; Sulfonamides; Tamsulosin	2016
Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia. The Journal of urology, 2017, Volume: 197, Issue:1 Topics: Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Testosterone	2017
Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α The Prostate, 2017, Volume: 77, Issue:7 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Cells, Cultured; Endothelins; Humans; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Prostate; Prostatic Hyperplasia; Statistics as Topic; Sulfonamides; Tamsulosin; Vasoconstrictor Agents	2017
Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study. Neurourology and urodynamics, 2017, Volume: 36, Issue:8 Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscle, Smooth; Organ Size; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics	2017
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation. Annals of ophthalmology (Skokie, Ill.), 2008,Spring, Volume: 40, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume. Journal of Korean medical science, 2008, Volume: 23, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Logistic Models; Male; Middle Aged; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Retrospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome	2008
[Examination of the mechanism of ameliorating effect of alpha 1-blocker on storage symptoms associated with benign prostatic hyperplasia]. Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Female; Male; Prostatic Hyperplasia; Rabbits; Rats; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive	2008
How many drugs for LUTS due to BPH are too many? The Journal of urology, 2008, Volume: 180, Issue:3 Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride	2008
By the way, doctor. I have been taking Avodart for my BPH, along with Flomax, but finasteride may be less expensive. Should I switch? Harvard health letter, 2008, Volume: 33, Issue:9 Topics: Antineoplastic Agents; Drug Therapy, Combination; Drugs, Generic; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2008
Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications. The Journal of the American Osteopathic Association, 2009, Volume: 109, Issue:1 Topics: Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Iris; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2009
RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia. European journal of pharmacology, 2009, Apr-01, Volume: 607, Issue:1-3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; CHO Cells; Cricetinae; Cricetulus; Dogs; Humans; Injections, Intravenous; Male; Muscle Contraction; Phenylephrine; Phthalimides; Piperazines; Prostate; Prostatic Hyperplasia; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Spleen; Sulfonamides; Tamsulosin	2009
Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia. European journal of pharmacology, 2009, Jun-24, Volume: 613, Issue:1-3 Topics: Adrenergic alpha-Antagonists; Aging; Animals; Blood Pressure; Cardiovascular System; Dogs; Heart Rate; Indoles; Male; Organ Size; Pressure; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra	2009
Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome. Ophthalmology, 2009, Volume: 116, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cross-Sectional Studies; Eye Color; Glaucoma; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Muscle, Smooth; Ocular Hypertension; Prazosin; Prospective Studies; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin; Tomography, Optical Coherence	2009
Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery. JAMA, 2009, May-20, Volume: 301, Issue:19 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cataract Extraction; Contraindications; Endophthalmitis; Humans; Male; Postoperative Complications; Prostatic Hyperplasia; Retinal Detachment; Risk Factors; Sulfonamides; Tamsulosin	2009
Tamsulosin and the intraoperative floppy iris syndrome. JAMA, 2009, May-20, Volume: 301, Issue:19 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cataract Extraction; Contraindications; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Postoperative Complications; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2009
[The changes of prostate specific antigen (PSA) after treatment with alpha 1-adrenergic receptor antagonists in men with 4.0-9.9 ng/ml PSA level--a study for comparison of benign prostatic hyperplasia/lower urinary tract symptom (BPH/LUTS) and prostate ca Hinyokika kiyo. Acta urologica Japonica, 2009, Volume: 55, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urinary Retention	2009
Intraoperative floppy-iris syndrome: role of the bimanual approach. Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Prostatic Hyperplasia; Pupil; Receptors, Adrenergic, alpha-1; Sulfonamides; Syndrome; Tamsulosin	2009
Floppy iris syndrome: why BPH treatment can complicate cataract surgery. American family physician, 2009, Jun-15, Volume: 79, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2009
Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder. Biomedical research (Tokyo, Japan), 2009, Volume: 30, Issue:5 Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Animals; Benzilates; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive	2009
Alpha1-adrenergic blockers and intraoperative floppy-iris syndrome. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Case-Control Studies; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2009
Assessment of patient-reported outcome of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and treated with tamsulosin HCl in Korea. Urology, 2010, Volume: 75, Issue:5 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Republic of Korea; Sulfonamides; Tamsulosin; Treatment Outcome	2010
Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride. Scandinavian journal of urology and nephrology, 2010, Volume: 44, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Naphthalenes; Pilot Projects; Piperazines; Prognosis; Prostatic Hyperplasia; Prostatism; Retrospective Studies; Sulfonamides; Tamsulosin; Time Factors	2010
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. Ophthalmology, 2010, Volume: 117, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anthropometry; Case-Control Studies; Cataract Extraction; Dose-Response Relationship, Drug; Humans; Intraoperative Complications; Iris; Iris Diseases; Lens Implantation, Intraocular; Male; Middle Aged; Muscle, Smooth; Prostatic Hyperplasia; Retrospective Studies; Stromal Cells; Sulfonamides; Syndrome; Tamsulosin	2010
Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology, 2010, Volume: 76, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Double-Blind Method; Ejaculation; Humans; Indoles; Male; Middle Aged; Patient Acceptance of Health Care; Patient Dropouts; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfonamides; Tamsulosin	2010
Pharmacologic prophylaxis and risk factors for intraoperative floppy-iris syndrome in phacoemulsification performed by resident physicians. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Anesthetics, Combined; Anesthetics, Local; Epinephrine; Humans; Incidence; Intraoperative Complications; Iris Diseases; Lidocaine; Male; Prostatic Hyperplasia; Pupil; Retrospective Studies; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2010
Tamsulosin and intraoperative 'floppy iris' syndrome--keeping an eye on the problem. BJU international, 2010, Volume: 106, Issue:1 Topics: Adrenergic alpha-Antagonists; Humans; Iris Diseases; Male; Prostatic Hyperplasia; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2010
Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension. Prostate cancer and prostatic diseases, 2010, Volume: 13, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Models, Biological; Polypharmacy; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2010
[Clinical effects of increase in the loading dose of tamsulosin (from 0.2 mg to 0.3 mg) on urinary disturbance associated with benign prostate hyperplasia]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urination Disorders	2010
A time and place for brand names. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Drug Labeling; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin; Terminology as Topic	2010
Resident-performed phacoemulsification surgery in tamsulosin-treated patients. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Ophthalmology; Phacoemulsification; Practice Patterns, Physicians'; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Sulfonamides; Tamsulosin; Visual Acuity	2010
Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia. Neurourology and urodynamics, 2010, Volume: 29, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Japan; Male; Middle Aged; Nocturia; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Quality of Life; Sleep; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Incontinence; Urodynamics	2010
Editorial comment to short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2010, Volume: 17, Issue:10 Topics: Adrenergic alpha-Antagonists; Humans; Indoles; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2010
Implications of MHRA's reclassification of tamsulosin. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cataract Extraction; Consumer Product Safety; Drug and Narcotic Control; Drug Approval; Drug Labeling; Government Agencies; Humans; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prostatic Hyperplasia; Pupil; Sulfonamides; Tamsulosin; United Kingdom	2010
Risky cataract surgery and ophthalmic trainees. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Clinical Competence; Education, Medical, Graduate; Humans; Internship and Residency; Intraoperative Complications; Iris Diseases; Male; Ophthalmology; Prostatic Hyperplasia; Pupil; Risk Factors; Sulfonamides; Tamsulosin	2010
Tamsulosin and iris pigmentation. Ophthalmology, 2010, Volume: 117, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anthropometry; Cataract Extraction; Dose-Response Relationship, Drug; Humans; Hypopigmentation; Intraoperative Complications; Iris; Male; Melanins; Muscle, Smooth; Pigment Epithelium of Eye; Prostatic Hyperplasia; Stromal Cells; Sulfonamides; Syndrome; Tamsulosin	2010
Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population. Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:4 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Dutasteride; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Humans; India; Logistic Models; Male; Middle Aged; Polymorphism, Genetic; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2010
An older adult man who is unable to sleep: advocating self-care in home healthcare. Home healthcare nurse, 2011, Volume: 29, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Home Care Services; Home Nursing; Humans; Male; Prostatic Hyperplasia; Self Care; Sleep Deprivation; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urination Disorders	2011
Annual drug update: 2010 in review. The Nurse practitioner, 2011, Volume: 36, Issue:2 Topics: Amlodipine; Antihypertensive Agents; Azasteroids; Clindamycin; Dermatologic Agents; Drug Combinations; Dutasteride; Humans; Hydrochlorothiazide; Imidazoles; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tetrazoles; Tretinoin; United States; United States Food and Drug Administration	2011
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia. Urology, 2011, Volume: 77, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography	2011
[Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain]. Actas urologicas espanolas, 2011, Volume: 35, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cost-Benefit Analysis; Drug Therapy, Combination; Dutasteride; Humans; Male; Prostatic Hyperplasia; Spain; Sulfonamides; Tamsulosin	2011
Correlation between urological alpha1-AR antagonist medication and changed intraoperative iris behavior. International ophthalmology, 2011, Volume: 31, Issue:2 Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Epinephrine; Female; Humans; Intraoperative Complications; Iris Diseases; Male; Phacoemulsification; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin	2011
[Comment to: «Cost-Effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain»]. Actas urologicas espanolas, 2011, Volume: 35, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cost-Benefit Analysis; Drug Therapy, Combination; Dutasteride; Humans; Male; Prostatic Hyperplasia; Spain; Sulfonamides; Tamsulosin	2011
Editorial comment to Tamsulosin versus transurethral resection of the prostate: effect on nocturia due to benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Male; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate	2011
The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the combination of avodart and tamsulosin (CombAT) s BJU international, 2011, Volume: 107, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Humans; Male; Prostatic Hyperplasia; Prostatism; Sulfonamides; Tamsulosin	2011
Effect of tamsulosin on ejaculatory function in BPH/LUTS. Asian journal of andrology, 2011, Volume: 13, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Ejaculation; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin	2011
Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia. The Journal of urology, 2011, Volume: 186, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Humans; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Up-Regulation	2011
Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia. Urology, 2011, Volume: 78, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Male; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive	2011
Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial. BJU international, 2012, Volume: 109, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Cost-Benefit Analysis; Drug Therapy, Combination; Dutasteride; Humans; Male; Markov Chains; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2012
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes. Journal of pharmacy practice, 2012, Volume: 25, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2012
Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype. Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Humans; Kinetics; Male; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Sulfonamides; Tamsulosin	2012
The effect of alpha antagonists on pupil dynamics: implications for the diagnosis of intraoperative floppy iris syndrome. American journal of ophthalmology, 2012, Volume: 153, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Case-Control Studies; Cataract Extraction; Diagnostic Techniques, Ophthalmological; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle Hypotonia; Muscle, Smooth; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Tamsulosin	2012
Dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic enlargement. Drugs of today (Barcelona, Spain : 1998), 2012, Volume: 48, Issue:1 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Dihydrotestosterone; Drug Combinations; Dutasteride; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Testosterone	2012
Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms? European urology, 2012, Volume: 61, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Vasodilator Agents	2012
Intra-operative floppy iris syndrome. Journal of the Indian Medical Association, 2011, Volume: 109, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Cataract Extraction; Humans; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2011
Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. The journal of sexual medicine, 2012, Volume: 9, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Carbolines; Electric Stimulation; Humans; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin; Urinary Bladder	2012
Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia. Medical archives (Sarajevo, Bosnia and Herzegovina), 2012, Volume: 66, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2012
[Management of intraoperative floppy iris syndrome]. Oftalmologia (Bucharest, Romania : 1990), 2012, Volume: 56, Issue:1 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Aged; Cataract Extraction; Chondroitin Sulfates; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyaluronic Acid; Incidence; Injections, Intraocular; Intraoperative Care; Iris Diseases; Male; Phenylephrine; Preoperative Care; Prostatic Hyperplasia; Pupil; Retrospective Studies; Romania; Sulfonamides; Syndrome; Tamsulosin; Treatment Outcome	2012
Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2013, Volume: 22, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Health Status; Health Surveys; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sickness Impact Profile; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2013
Editorial Comment to tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men. International journal of urology : official journal of the Japanese Urological Association, 2013, Volume: 20, Issue:2 Topics: Carbolines; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sulfonamides; Tadalafil; Tamsulosin	2013
Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats. British journal of pharmacology, 2013, Volume: 168, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Aged; Anesthesia; Animals; Blood Pressure; Chlorocebus aethiops; COS Cells; Elapid Venoms; Epinephrine; Humans; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Peptides; Phenylephrine; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra	2013
Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia. The aging male : the official journal of the International Society for the Study of the Aging Male, 2012, Volume: 15, Issue:4 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Outcome Assessment, Health Care; Prostatic Hyperplasia; Sulfonamides; Tablets; Taiwan; Tamsulosin; Urodynamics	2012
Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma. Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Finasteride; Glaucoma; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Vision Disorders	2013
Impact of four loci on serum tamsulosin hydrochloride concentration. Journal of human genetics, 2013, Volume: 58, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Asian People; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 8; Drug Administration Schedule; Female; Genetic Loci; Genome-Wide Association Study; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2013
Alpha-1 adrenergic antagonists in aircrew for the treatment of benign prostatic hypertrophy. Aviation, space, and environmental medicine, 2013, Volume: 84, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Aerospace Medicine; Dehydration; Humans; Lower Urinary Tract Symptoms; Male; Military Personnel; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2013
Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK. BJU international, 2013, Volume: 112, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cost-Benefit Analysis; Disease Progression; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Dutasteride; Humans; Male; Markov Chains; Middle Aged; Practice Guidelines as Topic; Prostatic Hyperplasia; Quality-Adjusted Life Years; State Medicine; Sulfonamides; Tamsulosin; Treatment Outcome; United Kingdom	2013
Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin. Urology, 2013, Volume: 81, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography; Urinary Bladder Neck Obstruction	2013
Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats. Neuroscience letters, 2002, Aug-02, Volume: 328, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Efferent Pathways; Female; Hypogastric Plexus; Injections, Spinal; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Parasympathetic Nervous System; Piperazines; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Spinal Cord; Sulfonamides; Tamsulosin; Urinary Bladder	2002
Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2002, Volume: 74, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Anthropometry; Follow-Up Studies; Humans; Male; Middle Aged; Muscle, Smooth; Organ Size; Pilot Projects; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Ultrasonography; Urinary Bladder; Urinary Bladder Neck Obstruction	2002
[Correction of urination disorders caused by benign prostatic hyperplasia in cardiac surgery]. Khirurgiia, 2003, Issue:1 Topics: Adrenergic alpha-Antagonists; Coronary Artery Bypass; Humans; Male; Middle Aged; Postoperative Complications; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2003
Nocturia and benign prostatic hyperplasia. Urology, 2003, Volume: 61, Issue:4 Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Humans; Male; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urination Disorders; Urodynamics	2003
[Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia]. Der Urologe. Ausg. A, 2003, Volume: 42, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics	2003
Transient circadian hyper-amplitude-tension (CHAT) may be intermittent: case reports illustrating gliding spectral windows. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2003, Volume: 57 Suppl 1 Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Data Interpretation, Statistical; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors	2003
Systemic contact dermatitis from tamsulosin. Contact dermatitis, 2003, Volume: 49, Issue:1 Topics: Antineoplastic Agents; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male; Middle Aged; Patch Tests; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2003
Herbal and vitamin supplement use in a prostate cancer screening population. Urology, 2004, Volume: 63, Issue:2 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins	2004
A life-threatening case of stenosing pill hypopharynx-oesophagitis caused by a tamsulosin capsule. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:9 Topics: Adrenergic alpha-Antagonists; Aged; Esophageal Stenosis; Esophagitis; Humans; Hypophosphatasia; Male; Pharyngitis; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tomography, X-Ray Computed	2004
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. The Journal of urology, 2004, Volume: 172, Issue:6 Pt 1 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Azasteroids; Doxazosin; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders	2004
[Use of alpha-adrenoblockers in therapy of benign prostatic hyperplasia in patients with arterial hypertension]. Terapevticheskii arkhiv, 2004, Volume: 76, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Antineoplastic Agents; Doxazosin; Humans; Hypertension; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2004
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2004
Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction. BJU international, 2005, Volume: 95, Issue:7 Topics: Acetylcholinesterase; Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Infusions, Intravenous; Male; Prostatic Hyperplasia; Pyrroles; Quinolones; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Retention; Urodynamics	2005
A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period. The Journal of urology, 2005, Volume: 173, Issue:6 Topics: Aged; Combined Modality Therapy; Costs and Cost Analysis; Cystoscopy; Drug Costs; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Medicare Assignment; Middle Aged; Models, Economic; Prostatic Hyperplasia; Retreatment; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; United States	2005
Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Phytotherapy; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Treatment Outcome; Urologic Diseases	2005
Intraoperative floppy iris syndrome associated with tamsulosin. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cataract Extraction; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin	2005
Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride. European urology, 2005, Volume: 48, Issue:2 Topics: Adrenergic alpha-Antagonists; Androgen Antagonists; Enzyme Inhibitors; Finasteride; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Serenoa; Sexual Behavior; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urodynamics	2005
Acute intoxication with tamsulosin hydrochloride. Clinical toxicology (Philadelphia, Pa.), 2005, Volume: 43, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Antineoplastic Agents; Bradycardia; Drug Overdose; Humans; Male; Muscle Hypotonia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2005
The use of tamsulosin and iris hypotony during cataract surgery. Acta ophthalmologica Scandinavica, 2005, Volume: 83, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Humans; Iris; Male; Phacoemulsification; Prolapse; Prostatic Hyperplasia; Pupil Disorders; Sulfonamides; Tamsulosin	2005
Intraoperative 'floppy iris' syndrome and its relationship to tamsulosin: a urologist's guide. BJU international, 2006, Volume: 97, Issue:1 Topics: Antineoplastic Agents; Humans; Iris; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2006
Intraoperative floppy iris syndrome associated with tamsulosin. BJU international, 2006, Volume: 97, Issue:1 Topics: Antineoplastic Agents; Cataract Extraction; Humans; Iris Diseases; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2006
[Ejaculatory disorder by alpha-1 adrenoceptor antagonist in patients with benign prostatic hyperplasia; retrospective comparison between naftopidil and tamsulosin]. Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Retrospective Studies; Sexual Dysfunctions, Psychological; Sulfonamides; Tamsulosin	2005
Effects of selective alpha-1-adrenergic receptor blockers on bladder weight. Urologia internationalis, 2006, Volume: 76, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Hypertrophy; Male; Middle Aged; Organ Size; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography; Urinary Bladder	2006
Are all alpha-blockers created the same? European urology, 2006, Volume: 49, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Clinical Trials as Topic; Dizziness; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2006
Intraoperative floppy iris syndrome associated with tamsulosin. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2005
Antipsychotic agent as an etiologic agent of IFIS. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Antipsychotic Agents; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2005
Intraoperative floppy iris syndrome associated with tamsulosin. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2005
Alpha antagonists in cataract surgery. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2005
[Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126 Spec no. Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Hypogastric Plexus; Indoles; Male; Naphthalenes; Piperazines; Pressure; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra	2006
How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors	2006
Discontinuation of tamsulosin treatment in men with lower urinary tract symptoms: a pilot study. Urologia internationalis, 2006, Volume: 76, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Pilot Projects; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2006
Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting. Current medical research and opinion, 2006, Volume: 22, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Primary Health Care; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2006
[Tamsulosin in the sustained-release capsule -- continuously effective and economical]. MMW Fortschritte der Medizin, 2006, Apr-27, Volume: 148, Issue:17 Topics: Adrenergic alpha-Antagonists; Capsules; Delayed-Action Preparations; Humans; Male; Middle Aged; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin	2006
Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology, 2006, Volume: 67, Issue:6 Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Polyuria; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2006
Use of epinephrine for IFIS prophylaxis. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:7 Topics: Adrenergic alpha-Antagonists; Anterior Chamber; Cataract Extraction; Epinephrine; Humans; Hydrogen-Ion Concentration; Iris Diseases; Male; Mydriatics; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2006
Prevalence and clinical findings of tamsulosin-associated intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Utilization; Humans; Intraoperative Complications; Iris Diseases; Lens Implantation, Intraocular; Male; Phacoemulsification; Prevalence; Prospective Studies; Prostatic Hyperplasia; Pupil; Sulfonamides; Surveys and Questionnaires; Syndrome; Tamsulosin; Time Factors; United Kingdom	2006
A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia. The Journal of urology, 2006, Volume: 176, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Female; Indoles; Male; Prazosin; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urinary Incontinence	2006
Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia. Neurourology and urodynamics, 2006, Volume: 25, Issue:7 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Carotid Artery, Common; Data Interpretation, Statistical; Dogs; Electric Stimulation; Heart Rate; Hypogastric Plexus; In Vitro Techniques; Indoles; Male; Naphthalenes; Norepinephrine; Organ Specificity; Piperazines; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra; Urethral Obstruction; Urinary Tract	2006
Influence of tamsulosin on the iris and its implications for cataract surgery. Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Aqueous Humor; Cataract Extraction; Humans; Iris; Iris Diseases; Male; Middle Aged; Miosis; Prolapse; Prostatic Hyperplasia; Pupil; Sulfonamides; Tamsulosin	2006
Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:9 Topics: Aged; Antineoplastic Agents; Health Status Indicators; Health Surveys; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Retention	2006
Intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Phacoemulsification; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2006
Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:10 Topics: Adrenergic alpha-Antagonists; Atropine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Ophthalmic Solutions; Phacoemulsification; Preoperative Care; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2006
Cataract surgery management in patients taking tamsulosin staged approach. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Cyclopentolate; Diclofenac; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Ophthalmic Solutions; Phacoemulsification; Phenylephrine; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2006
Iris tears secondary to intraoperative floppy-iris syndrome associated with tamsulosin. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Phacoemulsification; Prostatic Hyperplasia; Rupture; Sulfonamides; Syndrome; Tamsulosin	2006
Intraoperative floppy-iris syndrome associated with tamsulosin. Journal of cataract and refractive surgery, 2006, Volume: 32, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Cataract Extraction; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2006
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist. American journal of ophthalmology, 2007, Volume: 143, Issue:1 Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2007
Choroidal detachment following the use of tamsulosin (Flomax). American journal of ophthalmology, 2007, Volume: 143, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Cataract Extraction; Choroid Diseases; Humans; Lens Implantation, Intraocular; Male; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Recurrence; Sulfonamides; Tamsulosin; Ultrasonography	2007
Variations in intake of tamsulosin. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Drug Prescriptions; Drug Utilization; Humans; Intraoperative Complications; Iris Diseases; Lens Implantation, Intraocular; Male; Phacoemulsification; Practice Patterns, Physicians'; Prevalence; Prostatic Hyperplasia; Pupil; Sulfonamides; Tamsulosin; United Kingdom; United States	2007
Preoperative atropine in IFIS. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:3 Topics: Adrenergic alpha-Antagonists; Antineoplastic Agents; Atropine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Ophthalmic Solutions; Phacoemulsification; Preoperative Care; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2007
Treatment of men with lower urinary tract symptoms and overactive bladder. JAMA, 2007, Mar-21, Volume: 297, Issue:11 Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Drug Therapy, Combination; Humans; Male; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge	2007
Treatment of men with lower urinary tract symptoms and overactive bladder. JAMA, 2007, Mar-21, Volume: 297, Issue:11 Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Interactions; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence, Urge	2007
Intraoperative floppy-iris syndrome with doxazosin. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Prospective Studies; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin	2007
Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway. Scandinavian journal of urology and nephrology, 2007, Volume: 41, Issue:2 Topics: Azasteroids; Costs and Cost Analysis; Dutasteride; Finasteride; Humans; Male; Norway; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Transurethral Resection of Prostate	2007
Iris prolapse and the floppy-iris syndrome. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Antineoplastic Agents; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Phacoemulsification; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2007
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist. American journal of ophthalmology, 2007, Volume: 143, Issue:6 Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Doxazosin; Female; Humans; Hypertension; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2007
Prophylaxis for IFIS. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Atropine; Cataract Extraction; Drug Therapy, Combination; Epinephrine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Preservatives, Pharmaceutical; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2007
Intraoperative floppy-iris syndrome: do we know everything about it? Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Intraoperative Complications; Iris Diseases; Male; Phacoemulsification; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2007
Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Odds Ratio; Phacoemulsification; Postoperative Complications; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2007
Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study. International urology and nephrology, 2007, Volume: 39, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Prazosin; Prospective Studies; Prostatic Hyperplasia; Pyridines; Quality of Life; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics; Zolpidem	2007
Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourology and urodynamics, 2008, Volume: 27, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Muscle, Smooth; Prostate; Prostatic Hyperplasia; Retrospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics	2008
The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms. BJU international, 2007, Volume: 100, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Cross-Sectional Studies; Erectile Dysfunction; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatism; Quality of Life; Regression Analysis; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome	2007
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia with overactive bladder]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2007, Volume: 98, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive	2007
Intraoperative floppy iris syndrome associated with tamsulosin. Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:7 Topics: Cataract Extraction; Follow-Up Studies; Humans; Intraoperative Complications; Iris Diseases; Male; Prostatic Hyperplasia; Risk Assessment; Sulfonamides; Syndrome; Tamsulosin	2007
Postoperative finding in the intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Atrophy; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Phacoemulsification; Postoperative Complications; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin	2007
alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU international, 2008, Volume: 101, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Animals; Case-Control Studies; Chronic Disease; Humans; Ischemia; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatism; Sulfonamides; Swine; Tamsulosin; Treatment Outcome; Ultrasonography; Urinary Bladder; Urodynamics	2008
[Some problems for dosage form based on questionnaire surveying compliance in patients taking tamsulosin hydrochloride]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:2 Topics: Aged; Aged, 80 and over; Dosage Forms; Humans; Male; Patient Compliance; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders	2008
New practical synthesis of Tamsulosin. Chirality, 2008, Volume: 20, Issue:6 Topics: Acetone; Adrenergic alpha-Antagonists; Amines; Chemistry, Pharmaceutical; Humans; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Prostatic Hyperplasia; Spectrophotometry, Infrared; Stereoisomerism; Sulfonamides; Tamsulosin	2008
Awareness of IFIS among primary care physicians. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Clinical Competence; Health Knowledge, Attitudes, Practice; Humans; Intraoperative Complications; Iris Diseases; Male; Physicians, Family; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin	2008
Role of intracellular Ca2+ stores in smooth muscle contractions of the guinea pig vas deferens. Urological research, 1993, Volume: 21, Issue:5 Topics: Adrenergic alpha-Antagonists; Animals; Calcium; Calcium Channels; Guinea Pigs; Humans; In Vitro Techniques; Intracellular Fluid; Male; Models, Biological; Muscle Contraction; Muscle, Smooth; Nifedipine; Phenylephrine; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Vas Deferens	1993
High-affinity specific [3H]tamsulosin binding to alpha 1-adrenoceptors in human prostates with benign prostatic hypertrophy. Urological research, 1994, Volume: 22, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Prostatic Hyperplasia; Radioligand Assay; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1994
Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate. The Journal of urology, 1993, Volume: 149, Issue:2 Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Epinephrine; Male; Muscle Contraction; Phenoxybenzamine; Prazosin; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Sulfonamides; Tamsulosin	1993
Quantitative autoradiography of alpha 1 adrenoceptors with [3H]tamsulosin in human hypertrophied prostate using computerized image analysis. The Histochemical journal, 1995, Volume: 27, Issue:12 Topics: Adrenergic alpha-Antagonists; Aged; Autoradiography; Humans; Image Processing, Computer-Assisted; Ligands; Male; Membranes; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1995
Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation. European journal of pharmacology, 1996, Jun-03, Volume: 305, Issue:1-3 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Calcium Channel Blockers; Electric Stimulation; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Nifedipine; Norepinephrine; Phenylephrine; Potassium; Prazosin; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1996
Transition zone ratio and prostate-specific antigen density: the index of response of benign prostatic hypertrophy to an alpha blocker. International journal of urology : official journal of the Japanese Urological Association, 1996, Volume: 3, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostate-Specific Antigen; Prostatic Hyperplasia; Radioimmunoassay; Retrospective Studies; Sulfonamides; Tamsulosin; Ultrasonography; Urodynamics	1996
[Tamsulosin--the first selective alpha 1A-adrenergic receptor blocker in the treatment of BPH (benign prostatic hypertrophy)]. Deutsche medizinische Wochenschrift (1946), 1996, Volume: 121, Issue:33 Suppl Topics: Adrenergic alpha-Antagonists; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1996
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs. Pharmacology, 1996, Volume: 53, Issue:6 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Doxazosin; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethra	1996
[The concentration of Tamsulosin hydrochloride in the blood and prostatic tissue of the patients in benign prostatic hyperplasia]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1997, Volume: 88, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Biological Transport; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1997
Effect of the alpha-1 adrenoceptor blocker on tissue norepinephrine contents in human benign prostatic hyperplasia. International urology and nephrology, 1997, Volume: 29, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Chromatography, High Pressure Liquid; Humans; Male; Muscle, Smooth; Norepinephrine; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1997
KMD-3213, a novel alpha1A-adrenoceptor antagonist, potently inhibits the functional alpha1-adrenoceptor in human prostate. European journal of pharmacology, 1997, Jul-16, Volume: 331, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Indoles; Male; Muscle Contraction; Norepinephrine; Prazosin; Prostate; Prostatectomy; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
Tamsulosin for benign prostatic hyperplasia. The Medical letter on drugs and therapeutics, 1997, Oct-10, Volume: 39, Issue:1011 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Costs and Cost Analysis; Humans; Hypotension, Orthostatic; Intestinal Absorption; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1997
Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group. European urology, 1997, Volume: 32, Issue:4 Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Pulse; Randomized Controlled Trials as Topic; Retrospective Studies; Sulfonamides; Tamsulosin; Urologic Diseases	1997
In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia. Life sciences, 1998, Volume: 62, Issue:17-18 Topics: Adrenergic alpha-Antagonists; Animals; Cresols; Indoles; Male; Prazosin; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tissue Distribution	1998
Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? The Journal of urology, 1998, Volume: 160, Issue:3 Pt 1 Topics: Adrenergic alpha-Antagonists; Drug Tolerance; Humans; Hypertension; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Tamsulosin: real life clinical experience in 19,365 patients. European urology, 1998, Volume: 34 Suppl 2 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction	1998
[Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only]. Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:8 Topics: Adrenergic alpha-Antagonists; Aged; Chlormadinone Acetate; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Progesterone Congeners; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Benign prostatic hyperplasia: maximizing treatment with alpha blockers. Geriatrics, 1998, Volume: 53 Suppl 2 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urodynamics	1998
Tamsulosin: the United States trials. Geriatrics, 1998, Volume: 53 Suppl 2 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Hypotension, Orthostatic; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; United States	1998
Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy. Urology, 1999, Volume: 54, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Combined Modality Therapy; Diathermy; Humans; Male; Microwaves; Middle Aged; Prostatic Hyperplasia; Quality of Life; Retrospective Studies; Sulfonamides; Tamsulosin; Urethra; Urinary Catheterization; Urination Disorders; Urodynamics	1999
KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Drug Interactions; Humans; Indoles; Injections, Intravenous; Male; Phenylephrine; Prostate; Prostatic Hyperplasia; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Sulfonamides; Tamsulosin; Urinary Tract Physiological Phenomena	1999
By the way, doctor... I'm 78 and have more and more difficulty urinating. I get up three times a night - sometimes more - to go to the bathroom and it takes me a while to start urinating and even longer to stop. I know that this is probably a prostate pro Harvard health letter, 1999, Volume: 24, Issue:12 Topics: Adrenergic alpha-Antagonists; Aged; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	1999
Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. The Journal of urology, 2000, Volume: 163, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Diabetes Complications; Humans; Logistic Models; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urodynamics	2000
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease. The Prostate. Supplement, 2000, Volume: 9 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin	2000
Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin? BJU international, 2001, Volume: 87, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Humans; Logistic Models; Male; Prostatic Hyperplasia; Quality of Life; Sexual Behavior; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Retention	2001
Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations. Journal of clinical epidemiology, 2001, Volume: 54, Issue:5 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Adult; Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Finasteride; Humans; Male; Middle Aged; Morbidity; Netherlands; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Research Design; Risk Factors; Sulfonamides; Tamsulosin	2001
Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data. BJU international, 2001, Volume: 87, Issue:9 Topics: Adrenergic alpha-Antagonists; Adverse Drug Reaction Reporting Systems; Aged; Cohort Studies; Drug Prescriptions; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2001
Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia. The Journal of urology, 2001, Volume: 166, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urination Disorders; Urodynamics	2001
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia. International urology and nephrology, 2001, Volume: 32, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2001
Results of treatment with tamsulosin in men with acute urinary retention. Techniques in urology, 2001, Volume: 7, Issue:4 Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Regression Analysis; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urinary Retention	2001
Lower urinary tract symptoms: what are the implications for the patients? European urology, 2001, Volume: 40 Suppl 4 Topics: Adrenergic alpha-Antagonists; Data Collection; Europe; Finasteride; Humans; Life Style; Male; Patient Acceptance of Health Care; Penile Erection; Prevalence; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urinary Retention	2001
[Transition zone index in predicting therapeutic efficacy of benign prostatic hyperplasia]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2002, Volume: 93, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Predictive Value of Tests; Prostatic Hyperplasia; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Sulfonamides; Tamsulosin; Ultrasonography	2002
Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. The Journal of urology, 2002, Volume: 167, Issue:4 Topics: Adrenergic beta-Antagonists; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Time Factors; Treatment Failure	2002